{
  "meta": {
    "title": "Late_Night_Pyq_Pyt_Medicine-8",
    "url": "https://brainandscalpel.vercel.app/late-night-pyq-pyt-medicine-8-e1e9b500.html",
    "scrapedAt": "2025-11-29T18:10:06.776Z"
  },
  "questions": [
    {
      "id": 48130,
      "choices": [
        {
          "id": 192115,
          "text": "<p>Washerman stomach</p>"
        },
        {
          "id": 192116,
          "text": "<p>Watermelon stomach</p>"
        },
        {
          "id": 192117,
          "text": "<p>Windmill stomach</p>"
        },
        {
          "id": 192118,
          "text": "<p>Windshield stomach</p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Gastric antral vascular ectasia is responsible for which of the following appearances? (NEET PG 2015)</span></p>",
      "unique_key": "Q8958362",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731563,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Correct Answer: B. Watermelon stomach</strong>.</p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Gastric antral vascular ectasia (GAVE) is characterized by its distinctive endoscopic appearance resembling the stripes of a watermelon, hence the name \"watermelon stomach.\" This condition features linear red streaks arranged in a radial pattern around the antrum of the stomach. These streaks represent dilated mucosal blood vessels that can cause chronic blood loss and iron deficiency anemia. GAVE is often associated with certain systemic conditions including portal hypertension, autoimmune disorders, and chronic renal failure.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Washerman stomach</strong>: This is not a recognized term for any specific gastric endoscopic finding. It does not describe the appearance of gastric antral vascular ectasia.</p><p>&nbsp;</p><p><strong>Option C. Windmill stomach</strong>: This is not a recognized term in gastroenterology for describing the appearance of gastric lesions or vascular abnormalities.</p><p>&nbsp;</p><p><strong>Option D. Windshield stomach</strong>: This is not a recognized term for any specific gastric endoscopic finding. It is not used to describe gastric antral vascular ectasia or any other known gastric condition.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Gastric antral vascular ectasia produces a characteristic endoscopic appearance called \"watermelon stomach\" with red stripes resembling a watermelon, representing dilated blood vessels that can cause chronic blood loss.</p>",
      "correct_choice_id": 192116,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 92164,
      "choices": [
        {
          "id": 366972,
          "text": "<p><span style=\"font-size:14.0pt;\">Mesangial expansion</span></p>"
        },
        {
          "id": 366973,
          "text": "<p><span style=\"font-size:14.0pt;\">Armanni-Ebstein lesion</span></p>"
        },
        {
          "id": 366974,
          "text": "<p><span style=\"font-size:14.0pt;\">Podocyte loss</span></p>"
        },
        {
          "id": 366975,
          "text": "<p><span style=\"font-size:14.0pt;\">Kimmelstiel-Wilson nodules</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following lesions is not typically seen as a glomerular finding in patients with diabetic nephropathy? (INICET MAY 2025)</span></p>",
      "unique_key": "Q7487473",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731564,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Armanni-Ebstein lesion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The Armanni-Ebstein lesion is not a glomerular finding and is not specifically associated with diabetic nephropathy.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Armanni-Ebstein lesions are glycogen accumulations that occur in the tubules, specifically in the proximal convoluted tubules (PCT), not in the glomeruli. These lesions are seen in patients with diabetic ketoacidosis (DKA) and severe, uncontrolled hyperglycemia, but they are not part of the pathognomonic changes of diabetic nephropathy.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mesangial expansion:</strong> This is one of the earliest glomerular changes in diabetic kidney disease, occurring due to deposition of extracellular matrix in the mesangium.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Podocyte loss:</strong> Podocyte loss is a characteristic glomerular finding in diabetic nephropathy and contributes to proteinuria and progressive kidney disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Kimmelstiel-Wilson nodules:</strong> These represent nodular glomerulosclerosis and are the classic, pathognomonic glomerular change of diabetic nephropathy/diabetic kidney disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Armanni-Ebstein lesions are tubular (not glomerular) glycogen accumulations seen in DKA and severe hyperglycemia, not a specific finding of diabetic nephropathy.</span></p>",
      "correct_choice_id": 366973,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92164/INI_CET_May_2025_Medicine_Q_-_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92164/INI_CET_May_2025_Medicine_Q_-_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47626,
      "choices": [
        {
          "id": 190115,
          "text": "<p><span style=\"font-size:12.0pt;\">Glimepiride</span></p>"
        },
        {
          "id": 190116,
          "text": "<p><span style=\"font-size:12.0pt;\">Liraglutide</span></p>"
        },
        {
          "id": 190117,
          "text": "<p><span style=\"font-size:12.0pt;\">Acarbose</span></p>"
        },
        {
          "id": 190118,
          "text": "<p><span style=\"font-size:12.0pt;\">Empagliflozin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following anti-diabetic drugs can increase glucose excretion in urine?&nbsp;</span>(FMGE JANUARY 2024)</p>",
      "unique_key": "Q6869073",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731565,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Empagliflozin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Empagliflozin is <strong>an SGLT2 inhibitor</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Drugs in this class (such as empagliflozin, canagliflozin, and dapagliflozin) inhibit the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, leading to increased glucose excretion in the urine (glycosuria). This helps lower blood glucose levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Glimepiride:&nbsp;</strong>A sulfonylurea that stimulates insulin release from the pancreas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Liraglutide:&nbsp;</strong>A GLP-1 receptor agonist that increases insulin secretion, slows gastric emptying, and promotes satiety.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Acarbose:&nbsp;</strong>An alpha-glucosidase inhibitor that delays carbohydrate absorption in the intestines, leading to increased excretion of undigested carbohydrates in the stools.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Empagliflozin, an SGLT2 inhibitor, increases glucose excretion in the urine by inhibiting the sodium-glucose co-transporter 2 in the kidneys.</span></p>",
      "correct_choice_id": 190118,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47627,
      "choices": [
        {
          "id": 190119,
          "text": "<p><span style=\"font-size:12.0pt;\">Lorazepam followed by levetiracetam</span></p>"
        },
        {
          "id": 190120,
          "text": "<p><span style=\"font-size:12.0pt;\">Levetiracetam followed by valproate</span></p>"
        },
        {
          "id": 190121,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbamazepine followed by lorazepam</span></p>"
        },
        {
          "id": 190122,
          "text": "<p><span style=\"font-size:12.0pt;\">Valproate followed by gabapentin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 8-year-old child with a history of GTCS presented with 4-5 episodes of seizures, and seizures are present for more than 45 minutes. What will be the most appropriate management for this patient?&nbsp;</span>&nbsp;(FMGE JANUARY 2024)</p>",
      "unique_key": "Q4326119",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731566,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Lorazepam followed by levetiracetam</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the management of <strong>status epilepticus (SE)</strong>, <strong>the first line of treatment involves benzodiazepines. Lorazepam</strong> is preferred due to its rapid onset and longer duration of action compared to other benzodiazepines like diazepam or midazolam.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>First line treatment:&nbsp;</strong>Intravenous (IV) lorazepam (standard dose of 4 mg in adults; different doses for children).</span></li><li><span style=\"font-size:12.0pt;\"><strong>If seizures persist after the first dose of lorazepam,&nbsp;</strong>it can be repeated once.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Second line treatment:&nbsp;</strong>If seizures continue after two doses of lorazepam, IV anti-epileptic drugs (AEDs) are administered. Options include IV phenytoin, fosphenytoin, levetiracetam, valproate, or lacosamide.</span></li><li><span style=\"font-size:12.0pt;\">If still persist, intubate the patient, continuous EEG monitoring and give IV General anaesthesia (IV midazolam or IV propofol infusion)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this case, following lorazepam with levetiracetam is consistent with current guidelines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Levetiracetam followed by valproate:&nbsp;</strong>Levetiracetam is a second-line treatment, not first-line.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Carbamazepine followed by lorazepam:&nbsp;</strong>Carbamazepine is not typically used in the acute management of SE.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Valproate followed by gabapentin:&nbsp;</strong>Valproate can be used as a second-line treatment, but gabapentin is not typically used for SE management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The first line of management for status epilepticus is IV lorazepam, followed by IV antiepileptic drugs like levetiracetam if seizures persist.</span></p>",
      "correct_choice_id": 190119,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54284,
      "choices": [
        {
          "id": 216605,
          "text": "<p><span style=\"font-size:12.0pt;\">Soft tissue tumour in orbit</span></p>"
        },
        {
          "id": 216606,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroid eye disease</span></p>"
        },
        {
          "id": 216607,
          "text": "<p><span style=\"font-size:12.0pt;\">Optic nerve meningioma</span></p>"
        },
        {
          "id": 216608,
          "text": "<p><span style=\"font-size:12.0pt;\">Cavernous hemangioma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most common cause of proptosis in a middle-aged person?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q3439441",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731567,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Thyroid eye disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most common cause of proptosis in a middle-aged person is thyroid eye disease, also known as Graves' ophthalmopathy. This condition is associated with autoimmune thyroid disease, where the body's immune system mistakenly attacks the tissues around the eyes, leading to inflammation and swelling. This results in the characteristic bulging of the eyes, known as proptosis or exophthalmos.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thyroid eye disease is particularly common in middle-aged individuals and can cause both unilateral (one eye) and bilateral (both eyes) proptosis. The pathophysiology involves the expansion of the extraocular muscles and increased orbital fat, leading to the protrusion of the eye.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong> <strong>Soft tissue tumour in orbit</strong>: While soft tissue tumors in the orbit can cause proptosis, they are not the most common cause in middle-aged individuals. These tumors can be benign or malignant and require imaging studies for diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>Optic nerve meningioma</strong>: This type of tumor is associated with neurofibromatosis type 2 (NF2) and can lead to proptosis. However, it is less common compared to thyroid eye disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Cavernous hemangioma</strong>: Although cavernous hemangioma is the most common orbital tumor in adults, it is not the most common cause of proptosis. These benign vascular tumors can cause proptosis if they become large enough to displace the eye.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most common cause of proptosis in a middle-aged person is thyroid eye disease (Graves' ophthalmopathy).</span></p>",
      "correct_choice_id": 216606,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54284/INI-CET_May_2024Medicine_Question_29.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54284/INI-CET_May_2024Medicine_Question_29.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54285,
      "choices": [
        {
          "id": 216609,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased Renal Blood Flow</span></p>"
        },
        {
          "id": 216610,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased Glomerular hydrostatic pressure</span></p>"
        },
        {
          "id": 216611,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased Bowman's oncotic pressure</span></p>"
        },
        {
          "id": 216612,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased Glomerular oncotic pressure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A decrease in GFR is associated with which of the following?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q3009609",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731568,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Decreased Bowman's oncotic pressure</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">If the hydrostatic pressure of the capillaries or the oncotic pressure of the Bowman's capsule decreases, filtration will decrease. If the oncotic pressure in the glomerular capillary increases or if the hydrostatic pressure in the Bowman's capsule increases, GFR will decrease as well.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Glomerular filtration rate (GFR) is determined by the net filtration pressure, which depends on various pressures within the glomerulus and Bowman's capsule:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Increased Renal Blood Flow:</strong> This increases GFR as more blood flow leads to higher filtration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Increased Glomerular Hydrostatic Pressure:</strong> This also increases GFR because higher pressure in the glomerulus drives more filtrate into Bowman's capsule.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Decreased Glomerular Oncotic Pressure:</strong> This increases GFR because lower protein concentration in the glomerulus reduces the opposing force to filtration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Decreased Bowman's capsule oncotic pressure reduces net filtration pressure (NFP) and decreases glomerular filtration rate (GFR). Increased Bowman's capsule oncotic pressure increases filtration pressure and GFR.</span></p>",
      "correct_choice_id": 216611,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54285/INI-CET_May_2024Medicine_Question_30.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54285/INI-CET_May_2024Medicine_Question_30.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74895,
      "choices": [
        {
          "id": 298477,
          "text": "<p><span style=\"font-size:16px;\">24 hr urinary total metanephrines</span></p>"
        },
        {
          "id": 298478,
          "text": "<p><span style=\"font-size:16px;\">MIBG scan</span></p>"
        },
        {
          "id": 298479,
          "text": "<p><span style=\"font-size:16px;\">Plasma catecholamines</span></p>"
        },
        {
          "id": 298480,
          "text": "<p><span style=\"font-size:16px;\">MRI of the whole abdomen</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following is considered the initial recommended test for diagnosing pheochromocytoma? (INICET NOV 2024)</span></p>",
      "unique_key": "Q6566243",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731569,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) 24 hr urinary total metanephrines</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The 24-hour urinary metanephrines test is considered the gold standard and first-line test for diagnosing pheochromocytoma in the general population. The test should include fractionated catecholamines for comprehensive evaluation. This test is preferred due to its high sensitivity and specificity in detecting these rare neuroendocrine tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. MIBG scan:</strong> This is a nuclear medicine imaging test that can be useful for localizing pheochromocytoma and ruling out multifocal or metastatic disease, but it's not the initial diagnostic test. It's typically performed after biochemical confirmation of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Plasma catecholamines:</strong> While plasma catecholamines can be measured as part of the routine testing, they are not as reliable as urinary metanephrines due to their fluctuating levels and potential for false positives.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. MRI of the whole abdomen:</strong> This is an imaging study used for tumor localization after biochemical confirmation of pheochromocytoma. It's not appropriate as an initial diagnostic test.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">A 24-hour urinary metanephrines test with fractionated catecholamines is the initial recommended test for diagnosing pheochromocytoma in the general population. Plasma metanephrines can be considered in high-risk populations (such as those with a family history or genetic syndromes).</span></p>",
      "correct_choice_id": 298477,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74895/INI-CET_NOV_2024_Medicine_Q_-_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74895/INI-CET_NOV_2024_Medicine_Q_-_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50962,
      "choices": [
        {
          "id": 203389,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor X deficiency&nbsp;</span></p>"
        },
        {
          "id": 203390,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor VIII deficiency&nbsp;</span></p>"
        },
        {
          "id": 203391,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor IX deficiency&nbsp;</span></p>"
        },
        {
          "id": 203392,
          "text": "<p><span style=\"font-size:12.0pt;\">Von Willebrand Disease&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 26-year-old female presents to the ER with menorrhagia. She mentions that her father and sister also suffer from bleeding disorders. Which of the following is likely? </span><span style=\"font-size:10pt;\">(INICET NOV 2023)</span></p>",
      "unique_key": "Q4715248",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731570,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Von Willebrand Disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Von Willebrand Disease (vWD) is the most likely diagnosis given the family history of bleeding disorders and the patient's presentation with menorrhagia. vWD is an autosomal dominant condition affecting both males and females, characterized by defective platelet function due to a deficiency or dysfunction of von Willebrand factor. This leads to symptoms such as prolonged bleeding, menorrhagia, and prolonged bleeding after dental extractions or surgeries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Factor X deficiency: An</strong> extremely rare autosomal recessive condition that typically presents with joint bleeding (hemarthrosis) and intramuscular hematomas, which are more indicative of coagulation disorders rather than bleeding tendencies seen in platelet disorders.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Factor VIII deficiency:</strong> Known as Hemophilia A, this is an X-linked recessive disorder affecting mostly males. Females are typically carriers and rarely show symptoms. Hemophilia A presents with severe bleeding episodes and hemarthrosis, not usually menorrhagia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Factor IX deficiency</strong>: Known as Hemophilia B, this is also an X-linked recessive disorder affecting mostly males, with similar presentations to Hemophilia A, including severe bleeding episodes and hemarthrosis, not typically menorrhagia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Von Willebrand Disease is an autosomal dominant disorder presenting with bleeding symptoms like menorrhagia and is more common in females compared to Hemophilia A or B, which are X-linked recessive and primarily affect males.</span></p>",
      "correct_choice_id": 203392,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54291,
      "choices": [
        {
          "id": 216633,
          "text": "<p><span style=\"font-size:12.0pt;\">a, b</span></p>"
        },
        {
          "id": 216634,
          "text": "<p><span style=\"font-size:12.0pt;\">b, c</span></p>"
        },
        {
          "id": 216635,
          "text": "<p><span style=\"font-size:12.0pt;\">a, b, c</span></p>"
        },
        {
          "id": 216636,
          "text": "<p><span style=\"font-size:12.0pt;\">Only b</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Erythropoietin is secreted by which of the following?</span>&nbsp;(INICET MAY 2024)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">a. Liver</span><br><span style=\"font-size:12.0pt;\">b. Kidney</span><br><span style=\"font-size:12.0pt;\">c. Spleen</span><br><span style=\"font-size:12.0pt;\">d. Heart</span></p>",
      "unique_key": "Q5540668",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731571,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) a, b</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Erythropoietin (EPO) is a hormone responsible for stimulating the production of red blood cells in the bone marrow. The primary source of erythropoietin in the human body is the kidney, which accounts for about 90% of its production. The liver contributes approximately 10% of erythropoietin production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mechanism of Action:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>a. Liver:</strong> The liver produces erythropoietin mainly during fetal development, and its contribution decreases postnatally, although it continues to produce a small amount in adults.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>b. Kidney:</strong> Erythropoietin is mainly produced by <strong>interstitial fibroblast-like cells located in the renal cortex, particularly near the proximal convoluted tubules.</strong> The production of EPO in the kidneys is primarily regulated by oxygen levels; hypoxia (low oxygen levels) stimulates its secretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The spleen and heart are not known sources of erythropoietin production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option c &amp; d:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Neither the spleen nor the heart produce erythropoietin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Erythropoietin is primarily produced by the kidneys (90%) and to a lesser extent by the liver (10%). These organs are the main sources of erythropoietin in the human body, with the kidneys playing a dominant role in its regulation and production in response to hypoxia.</span></p>",
      "correct_choice_id": 216633,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54291/INI-CET_May_2024Medicine_Question_36.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54291/INI-CET_May_2024Medicine_Question_36.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54292,
      "choices": [
        {
          "id": 216637,
          "text": "<p><span style=\"font-size:12.0pt;\">Osmotic diuretics → Collecting duct</span></p>"
        },
        {
          "id": 216638,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbonic Anhydrase inhibitors → Proximal convoluted tubule</span></p>"
        },
        {
          "id": 216639,
          "text": "<p><span style=\"font-size:12.0pt;\">Thiazides → Loop of Henle</span></p>"
        },
        {
          "id": 216640,
          "text": "<p><span style=\"font-size:12.0pt;\">Aldosterone antagonists → Distal Convoluted tubule</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the correct match out of the following diuretics and the respective site of action:</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q2925626",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731572,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>B) Carbonic Anhydrase inhibitors → Proximal convoluted tubule</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Carbonic Anhydrase inhibitors</strong>: These diuretics inhibit the enzyme carbonic anhydrase, which is located predominantly in the <strong>proximal convoluted tubule.</strong> This inhibition reduces the reabsorption of bicarbonate, sodium, and water in this segment, making \"Carbonic Anhydrase inhibitors → Proximal convoluted tubule\" the correct match.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Osmotic diuretics</strong>: These have a diffuse mechanism of action throughout the nephron, primarily affecting water-permeable regions such as the <strong>proximal convoluted tubule and the descending limb of the loop of Henle</strong>. The statement \"Osmotic diuretics → Collecting duct\" is incorrect as the major sites of action are the proximal convoluted tubule and the descending limb, not just the collecting duct.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Thiazides</strong>: Thiazide diuretics act on the <strong>distal convoluted tubule</strong> by inhibiting the sodium-chloride transporter. They do not primarily act on the Loop of Henle, making \"Thiazides → Loop of Henle\" incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Aldosterone antagonists</strong>: These drugs act on the <strong>collecting ducts</strong>, particularly affecting the principal cells where aldosterone promotes sodium reabsorption and potassium secretion. Therefore, the statement \"Aldosterone antagonists → Distal Convoluted tubule\" is incorrect as their primary site of action is the collecting duct.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Diuretics with their site of action:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Osmotic diuretics → Proximal convoluted tubule and the descending limb of the loop of Henle</span></li><li><span style=\"font-size:12.0pt;\">Carbonic Anhydrase inhibitors → Proximal convoluted tubule</span></li><li><span style=\"font-size:12.0pt;\">Thiazides → Distal convoluted tubule</span></li><li><span style=\"font-size:12.0pt;\">Aldosterone antagonists → Collecting duct</span></li></ul>",
      "correct_choice_id": 216638,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54292/INI-CET_May_2024Medicine_Question_37.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54292/INI-CET_May_2024Medicine_Question_37.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11292,
      "choices": [
        {
          "id": 45134,
          "text": "<p><span style=\"font-size:12.0pt;\">Kerley B lines</span></p>"
        },
        {
          "id": 45135,
          "text": "<p><span style=\"font-size:12.0pt;\">Focal oligemia</span></p>"
        },
        {
          "id": 45136,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased venous blood in lung</span></p>"
        },
        {
          "id": 45137,
          "text": "<p><span style=\"font-size:12.0pt;\">Change in upper lobe circulation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a radiological finding in a patient with left heart failure? (NEET PG 2020)</span></p>",
      "unique_key": "Q4400520",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731573,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Focal oligemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Focal oligemia, also known as the Westermark sign, is a radiological finding indicative of pulmonary embolism, not heart failure. It represents a regional reduction in lung vascularity and is seen on chest radiographs as an area of decreased blood flow and enhanced clarity due to vascular obstruction from a clot.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Radiological Findings in Left Heart Failure:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Kerley B lines:&nbsp;</strong>These are thin linear opacities caused by interstitial edema, especially near the lung bases, and are commonly associated with congestive heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Increased venous blood in lung:&nbsp;</strong>Also known as pulmonary venous hypertension, this finding is due to increased pressure in the pulmonary veins that results from left heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Change in upper lobe circulation:&nbsp;</strong>This refers to the redistribution of blood flow to the upper lobes, a classic sign of pulmonary venous hypertension seen in left heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Further Stages of Left Heart Failure on CXR:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Stage 1 (PCWP 13-18 mmHg):&nbsp;</strong>Cardiomegaly, redistribution of pulmonary vessels, broad vascular pedicle.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Stage 2 (PCWP 18-25 mmHg):&nbsp;</strong>Kerley B lines and peribronchial cuffing indicating interstitial edema.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Stage 3 (PCWP &gt; 25 mmHg):&nbsp;</strong>Alveolar edema leading to consolidation and pleural effusion.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">In patients with suspected heart failure, radiological findings such as Kerley B lines, increased pulmonary venous pressure, and altered upper lobe circulation are indicative. Focal oligemia, however, suggests a differential diagnosis of pulmonary embolism and should prompt further investigation for this condition rather than heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/24/screenshot-2024-07-24-114523.jpg\" alt=\"\" width=\"929\" height=\"740\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Radiology assistant/ CXR in heart failure</strong></span></p>",
      "correct_choice_id": 45135,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16168,
      "choices": [
        {
          "id": 64632,
          "text": "<p><span style=\"font-size:12.0pt;\">Lanreotide depot formulation</span></p>"
        },
        {
          "id": 64633,
          "text": "<p><span style=\"font-size:12.0pt;\">Terlipressin</span></p>"
        },
        {
          "id": 64634,
          "text": "<p><span style=\"font-size:12.0pt;\">Ketoconazole</span></p>"
        },
        {
          "id": 64635,
          "text": "<p><span style=\"font-size:12.0pt;\">Leuprolide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 29-year-old male patient presents to the OPD with a 10-year history of coarse facial features and progressive enlargement of the hands and feet. Laboratory evaluation revealed elevated IGF-1 and non-suppressible growth hormone levels after the 75 g glucose challenge test. A diagnosis of acromegaly is made. Which of the following drugs is preferred for the management of this condition? (FMGE JAN 2023)</span></p>",
      "unique_key": "Q6619010",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731574,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A) Lanreotide depot formulation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acromegaly is a condition caused by excess growth hormone, often due to a growth hormone-secreting pituitary adenoma. The clinical features include coarse facial features and enlargement of the hands and feet. The diagnosis is confirmed with <strong>elevated IGF-1 levels</strong> <strong>and non-suppressible growth hormone levels </strong>following a glucose challenge test.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The first-line treatment&nbsp;</strong>for a growth hormone-secreting pituitary adenoma is <strong>transsphenoidal surgery</strong>. However, when surgery is not immediately possible or has failed, medical management is necessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The preferred drugs in these situations are <strong>somatostatin receptor agonists</strong>, such as <strong>lanreotide, octreotide, and pasireotide</strong>. Lanreotide depot formulation is effective in reducing growth hormone levels and controlling symptoms of acromegaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Terlipressin:</strong> Incorrect. Terlipressin is primarily used in the management of <strong>acute variceal bleeding</strong> related to liver conditions, not in the treatment of acromegaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Ketoconazole:</strong> Incorrect. Ketoconazole is used in managing <strong>Cushing's syndrome</strong> in children due to its ability to inhibit cortisol synthesis. It is not indicated for the treatment of acromegaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Leuprolide:</strong> Incorrect. Leuprolide is a GnRH analogue used in the management <strong>of gynecological conditions such as fibroids and in prostate cancer</strong>. It is not effective in treating acromegaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The preferred medical management for acromegaly, especially as a bridge to surgery or when surgery has failed, is the use of somatostatin receptor agonists like lanreotide depot formulation.</span></p>",
      "correct_choice_id": 64632,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20273,
      "choices": [
        {
          "id": 81053,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pancoast tumor</span></span></span></p>"
        },
        {
          "id": 81054,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Upper lobe pneumonia</span></span></span></p>"
        },
        {
          "id": 81055,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Superior vena cava obstruction</span></span></span></p>"
        },
        {
          "id": 81056,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aspergilloma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 65-year-old chronic smoker came to the medicine outpatient department with complaints of upper chest discomfort and drooping of an eyelid. He also complained of pain radiating to the upper arm and a tingling sensation in the 4th and 5th digits of his left hand. The chest X-ray is given below. What is the most likely diagnosis? (NEET PG 2023)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/31/screenshot-2024-07-30-170545.jpg\" style=\"height:334px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q6532495",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731575,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Pancoast tumor</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pancoast tumors, also known as superior sulcus tumors, are a type of lung cancer located at the apex (top) of the lung. These tumors are particularly associated with several key clinical features and findings, especially in chronic smokers:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Upper chest discomfort</span></strong><span style=\"font-size:12.0pt\">: This is a common symptom of a Pancoast tumor due to the tumor&#39;s location at the apex of the lung.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Drooping of an eyelid (ptosis)</span></strong><span style=\"font-size:12.0pt\">: This is part of Horner&#39;s syndrome, which occurs due to compression of the sympathetic nerves by the tumor. Horner&#39;s syndrome typically includes ptosis (drooping eyelid), miosis (constricted pupil), and anhidrosis (lack of sweating) on the affected side of the face.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pain radiating to the upper arm and tingling sensation</span></strong><span style=\"font-size:12.0pt\">: These symptoms suggest involvement of the brachial plexus, a network of nerves that supplies the arm and hand. Pancoast tumors often invade or compress these nerves, leading to referred pain and sensory disturbances in the arm and hand.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Chest X-ray findings</span></strong><span style=\"font-size:12.0pt\">: The provided chest X-ray shows a mass at the apex of the lung, which is characteristic of a Pancoast tumor.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/31/screenshot-2024-07-31-114511.jpg\" style=\"height:306px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Upper lobe pneumonia</span></strong><span style=\"font-size:12.0pt\">: While upper lobe pneumonia can cause chest discomfort and possibly pain, it is not associated with Horner&#39;s syndrome or brachial plexus involvement. The X-ray findings would also typically show consolidation rather than a mass.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Superior vena cava obstruction</span></strong><span style=\"font-size:12.0pt\">: This condition can cause swelling and discoloration of the face, neck, and upper extremities due to impaired blood flow. However, it does not explain the specific nerve-related symptoms like Horner&#39;s syndrome or tingling in the digits.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Aspergilloma</span></strong><span style=\"font-size:12.0pt\">: Aspergillomas are fungal balls that develop in pre-existing lung cavities, usually in patients with a history of tuberculosis or other lung diseases. They do not typically present with the neurological symptoms seen in this case, nor do they commonly cause Horner&#39;s syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pancoast tumors, or superior sulcus tumors, are associated with upper chest discomfort, Horner&#39;s syndrome, and neurological symptoms in the arm due to their apical location and propensity to invade local structures such as the brachial plexus and sympathetic nerves.</span></span></p>",
      "correct_choice_id": 81053,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16306,
      "choices": [
        {
          "id": 65184,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Interlobular septal thickenings</span></span></span></p>"
        },
        {
          "id": 65185,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Air bronchograms</span></span></span></p>"
        },
        {
          "id": 65186,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ground glass opacity</span></span></span></p>"
        },
        {
          "id": 65187,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Crazy paving pattern</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the most common pattern in CT of patients affected with COVID-19? (FMGE DEC 2021)</span></span></p>",
      "unique_key": "Q3311307",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731576,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Ground glass opacity</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ground glass opacities are the hallmark CT finding in COVID-19 pneumonia. These opacities represent partial filling of air spaces in the lungs and are a common feature seen in the early stages of the infection. They appear as hazy areas on the CT scan without complete consolidation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Interlobular septal thickenings</span></strong><span style=\"font-size:12.0pt\">: These are seen in various interstitial lung diseases but are not specific to COVID-19.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Air bronchograms</span></strong><span style=\"font-size:12.0pt\">: These can be seen in many types of pneumonia but are not the most common finding in COVID-19.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Crazy paving pattern</span></strong><span style=\"font-size:12.0pt\">: This pattern can appear in severe cases but is not as common as ground glass opacities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ground glass opacities are the most common CT finding in COVID-19 pneumonia.</span></span></span></p>",
      "correct_choice_id": 65186,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16451,
      "choices": [
        {
          "id": 65764,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis with metabolic compensation</span></p>"
        },
        {
          "id": 65765,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis with respiratory compensation</span></p>"
        },
        {
          "id": 65766,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory alkalosis with metabolic compensation</span></p>"
        },
        {
          "id": 65767,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis with respiratory compensation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The arterial blood gas findings of a patient are pH = 7.12, pCO2 = 50, HCO3 = 28. What is the diagnosis? (FMGE JUNE 2022)</span></p>",
      "unique_key": "Q6252499",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731577,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A) Respiratory acidosis with metabolic compensation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient’s pH of 7.12 indicates acidosis. The elevated pCO2 (normal ~40 mmHg) suggests a primary respiratory cause. The slightly elevated HCO3 indicates a compensatory metabolic response. Thus, the primary disorder is respiratory acidosis with metabolic compensation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Metabolic acidosis with respiratory compensation</strong>: Would show low HCO3 and low pCO2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Respiratory alkalosis with metabolic compensation</strong>: Would show high pH and low pCO2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Metabolic alkalosis with respiratory compensation</strong>: Would show high pH and high HCO3.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Respiratory acidosis with metabolic compensation is characterized by low pH, high pCO2, and a compensatory increase in HCO3.</span></p>",
      "correct_choice_id": 65764,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11206,
      "choices": [
        {
          "id": 44790,
          "text": "<p><span style=\"font-size:12.0pt;\">PaO2/FiO2 ratio 200-300 mm/Hg</span></p>"
        },
        {
          "id": 44791,
          "text": "<p><span style=\"font-size:12.0pt;\">Bilateral interstitial infiltrates</span></p>"
        },
        {
          "id": 44792,
          "text": "<p><span style=\"font-size:12.0pt;\">Symptom onset within a week</span></p>"
        },
        {
          "id": 44793,
          "text": "<p><span style=\"font-size:12.0pt;\">No cardiac failure on echocardiography</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">According to the berlin definition, moderate ARDS is characterized by all, except: (NEET PG 2018)</span></p>",
      "unique_key": "Q4992857",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731578,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. PaO2/FiO2 ratio 200-300 mm/Hg</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Berlin definition of Acute Respiratory Distress Syndrome (ARDS) classifies the severity based on the PaO2/FiO2 ratio assessed under specific conditions of oxygenation support. According to this definition, a PaO2/FiO2 ratio of 200-300 mmHg characterizes mild ARDS, not moderate ARDS. Moderate ARDS is defined by a PaO2/FiO2 ratio of 100-200 mm/Hg when assessed with at least 5 cm of water Positive End-Expiratory Pressure (PEEP).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Bilateral interstitial infiltrates:</strong> This is correct and consistent with all classifications of ARDS, which require bilateral opacities on imaging, either from chest radiographs or CT, indicative of pulmonary edema not fully explained by cardiac failure or fluid overload.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Symptom onset within a week:</strong> True for the Berlin definition, which stipulates that ARDS must occur within 7 days of a known clinical insult or new or worsening respiratory symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. No cardiac failure on echocardiography:</strong> Also true according to the Berlin definition, as the pulmonary edema should not be fully explained by cardiac failure or fluid overload, thus necessitating the exclusion of cardiac failure through echocardiography.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2012 Berlin Definition:</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12.0pt;\"><strong>Onset within 7 days&nbsp;</strong>after a known clinical insult or new or worsening respiratory symptoms</span></li><li><span style=\"font-size:12.0pt;\">B/L opacities (Alveolar/Interstitial that are <strong>\"consistent with pulmonary edema\"</strong> on chest radiographs or chest CT)</span></li><li><span style=\"font-size:12.0pt;\">Minimum PEEP setting or CPAP, 5 cm of water.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">PaO<sub>2</sub>: FiO<sub>2</sub> assessed on invasive mechanical ventilation (CPAP criterion used for the diagnosis of mild ARDS).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i><strong>Categorization of ARDS severity (on the basis of FiO<sub>2</sub>):</strong></i></span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12.0pt;\">Mild: 200-300</span></li><li><span style=\"font-size:12.0pt;\">Moderate: 100-200</span></li><li><span style=\"font-size:12.0pt;\">Severe: &lt;100</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In resource limited settings <i><strong>Kigali Modifications&nbsp;</strong></i>was proposed (2016):</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12.0pt;\">Bilateral opacities could be documented by <i>either ultrasonography or chest radiograph</i>.</span></li><li><span style=\"font-size:12.0pt;\">Oxygenation criteria: pulse oximetry oxygen saturation <i><strong>(SpO<sub>2</sub>)/FiO<sub>2</sub> ratio ≤ 315 without the requirement for PEEP.</strong></i></span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Respiratory Failure/Chap 301</strong></span></p>",
      "correct_choice_id": 44790,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "DiagnosisBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24775,
      "choices": [
        {
          "id": 99061,
          "text": "<p><span style=\"font-size:11.0pt;\">25</span></p>"
        },
        {
          "id": 99062,
          "text": "<p><span style=\"font-size:11.0pt;\">68</span></p>"
        },
        {
          "id": 99063,
          "text": "<p><span style=\"font-size:11.0pt;\">35</span></p>"
        },
        {
          "id": 99064,
          "text": "<p><span style=\"font-size:11.0pt;\">43</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A patient with chronic kidney disease has the following laboratory reports. Calculate the anion gap in this patient. Na<sup>+</sup>: 145 mEq/L, K<sup>+</sup> 4 mEq/L Cl: 90 mEq/L HCO3: 20 mEq/L. (INICET MAY 2023)</span></p>",
      "unique_key": "Q9165858",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731579,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C)&nbsp;35</strong></span></p><p><br><span style=\"font-size:12pt;\">The anion gap is calculated using the formula:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anion&nbsp;Gap = Na−(Cl+HCO3)</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\">Anion&nbsp;Gap=145−(90+20)=35</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The anion gap is calculated as Na - (Cl + HCO3), and a high anion gap may indicate metabolic acidosis.</span></p>",
      "correct_choice_id": 99063,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11336,
      "choices": [
        {
          "id": 45310,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyarteritis nodosa</span></span></p>"
        },
        {
          "id": 45311,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thromboangiitis obliterans</span></span></p>"
        },
        {
          "id": 45312,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Takayasu arteritis</span></span></p>"
        },
        {
          "id": 45313,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Microscopic polyangiitis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 36-year-old woman presented with claudication in the forearm, transient loss of vision, and abdominal pain. Femoral pulses were weak. Fundus examination revealed retinal hemorrhages. What is the likely diagnosis?</span> <span style=\"font-size:12.0pt\">(NEET PG 2021)</span></span></span></p>",
      "unique_key": "Q4108109",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731580,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C. Takayasu arteritis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Takayasu arteritis, also known as &quot;pulseless disease,&quot; is a large vessel vasculitis that primarily affects the aorta and its major branches. It is more common in young Asian females under 40 years old. The clinical presentation includes claudication (typically in the upper limbs due to subclavian artery involvement), weak pulses (particularly in the extremities), and symptoms resulting from ischemia in various organs (e.g., transient loss of vision due to carotid or vertebral artery involvement, abdominal pain due to mesenteric artery involvement).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of weak femoral pulses, claudication in the forearm, and retinal hemorrhages is characteristic of Takayasu arteritis. This condition can lead to narrowing or occlusion of major arteries, causing diminished blood flow to the affected regions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Polyarteritis nodosa:</span></strong><span style=\"font-size:12.0pt\"> Polyarteritis nodosa (PAN) is a medium vessel vasculitis that can cause abdominal pain, claudication, and other systemic symptoms, but it does not typically affect the large vessels and therefore would not explain the weak femoral pulses. PAN is often associated with hepatitis B infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Thromboangiitis obliterans:</span></strong><span style=\"font-size:12.0pt\"> Thromboangiitis obliterans (Buerger&#39;s disease) typically affects young male smokers and primarily involves the small and medium arteries of the extremities. It can cause claudication and ischemic symptoms in the limbs but does not typically cause weak femoral pulses or retinal hemorrhages.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Microscopic polyangiitis:</span></strong><span style=\"font-size:12.0pt\"> Microscopic polyangiitis (MPA) is a small vessel vasculitis that often presents with symptoms related to kidney and lung involvement (e.g., rapidly progressive glomerulonephritis and pulmonary hemorrhage). It does not typically present with claudication or weak pulses in the large vessels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Takayasu arteritis should be considered in young women presenting with symptoms of large vessel occlusion, such as claudication, weak pulses, and ischemic symptoms in various organs. It is characterized by the involvement of the aorta and its major branches, and the diagnosis can be confirmed with imaging studies like CT angiogram or conventional angiography.</span></span></p>",
      "correct_choice_id": 45312,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58580,
      "choices": [
        {
          "id": 233657,
          "text": "<p><span style=\"font-size:12.0pt;\">Methimazole</span></p>"
        },
        {
          "id": 233658,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbimazole</span></p>"
        },
        {
          "id": 233659,
          "text": "<p><span style=\"font-size:12.0pt;\">Propylthiouracil</span></p>"
        },
        {
          "id": 233660,
          "text": "<p><span style=\"font-size:12.0pt;\">Radioactive iodine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman at 8 weeks of gestation is diagnosed with hyperthyroidism. Which of the following is the most appropriate treatment option? (NEET PG 2024)</span></p>",
      "unique_key": "Q4397167",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731581,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Propylthiouracil</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">During pregnancy, the treatment of hyperthyroidism, especially in the first trimester, requires careful consideration due to the potential teratogenic effects of antithyroid drugs.</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>First Trimester Use of Propylthiouracil (PTU)</strong>: Propylthiouracil is the preferred antithyroid medication during the first trimester of pregnancy because it has a lower risk of causing congenital anomalies compared to methimazole and carbimazole. PTU is recommended to minimize the potential for teratogenic effects that are particularly associated with methimazole during early pregnancy.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Transition in Later Trimesters</strong>: In the second and third trimesters, the risk of liver toxicity with PTU increases, so it is common practice to switch back to methimazole or carbimazole as they are more effective and pose less hepatic risk compared to PTU.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Methimazole</strong>: Methimazole is generally avoided in the first trimester due to its association with congenital abnormalities, particularly aplasia cutis (a scalp defect) and choanal atresia. It is considered safer in the second and third trimesters.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Carbimazole</strong>: Carbimazole is converted to methimazole in the body and shares the same risks during the first trimester, hence it is not recommended during early pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Radioactive iodine</strong>: This treatment is absolutely contraindicated during pregnancy at any stage as it can destroy fetal thyroid tissue and lead to fetal hypothyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the first trimester of pregnancy, Propylthiouracil (PTU) is the preferred treatment for hyperthyroidism due to its lower teratogenic risk compared to other antithyroid drugs.</span></p>",
      "correct_choice_id": 233659,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58580/Neet_Pg_Aug_2024_Medicine_Q_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58580/Neet_Pg_Aug_2024_Medicine_Q_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58582,
      "choices": [
        {
          "id": 233665,
          "text": "<p><span style=\"font-size:12.0pt;\">Parkinson's disease</span></p>"
        },
        {
          "id": 233666,
          "text": "<p><span style=\"font-size:12.0pt;\">Graves' disease</span></p>"
        },
        {
          "id": 233667,
          "text": "<p><span style=\"font-size:12.0pt;\">Addison's disease</span></p>"
        },
        {
          "id": 233668,
          "text": "<p><span style=\"font-size:12.0pt;\">Alzheimer's disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young woman presents with weight loss, tachycardia, heat intolerance, and tremors. She has exophthalmos on examination. What is the diagnosis? (NEET PG 2024)</span></p>",
      "unique_key": "Q9828073",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731582,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Graves' disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Graves' disease is an autoimmune disorder that results in hyperthyroidism. It is characterized by symptoms such as weight loss, tachycardia, heat intolerance, tremors, and the presence of exophthalmos (protrusion of the eyeballs), which is a hallmark feature of Graves' disease. The condition arises due to the overproduction of thyroid hormones, leading to thyrotoxicosis. These clinical features are classic for Graves' disease and are not seen in the other conditions listed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Parkinson's disease:</strong> Parkinson's disease primarily affects motor function due to dopamine deficiency and is characterized by tremors, bradykinesia, rigidity, and postural instability. It does not present with symptoms like weight loss, heat intolerance, or exophthalmos, making it an incorrect choice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Addison's disease:</strong> Addison's disease involves adrenal insufficiency leading to symptoms such as fatigue, weight loss, hyperpigmentation, hypotension, and electrolyte imbalances. Heat intolerance, tachycardia, and exophthalmos are not associated with Addison’s disease, making this diagnosis unlikely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Alzheimer's disease:</strong> Alzheimer's disease is a neurodegenerative disorder characterized by memory loss, cognitive decline, and behavioral changes. It does not present with symptoms of hyperthyroidism such as tachycardia, heat intolerance, or exophthalmos, ruling it out as the correct answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Graves' disease should be suspected in patients presenting with symptoms of hyperthyroidism (weight loss, tachycardia, heat intolerance) along with exophthalmos, a distinguishing feature of the condition</span></p>",
      "correct_choice_id": 233666,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58582/Neet_Pg_Aug_2024_Medicine_Q_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58582/Neet_Pg_Aug_2024_Medicine_Q_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11351,
      "choices": [
        {
          "id": 45370,
          "text": "<p><span style=\"font-size:12.0pt;\">STEMI</span></p>"
        },
        {
          "id": 45371,
          "text": "<p><span style=\"font-size:12.0pt;\">NSTEMI</span></p>"
        },
        {
          "id": 45372,
          "text": "<p><span style=\"font-size:12.0pt;\">Stable Angina</span></p>"
        },
        {
          "id": 45373,
          "text": "<p><span style=\"font-size:12.0pt;\">Unstable Angina</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 74-year-old man with a history of dyslipidemia, hypertension, and aortic sclerosis presents to the emergency department with chest pain. He took 3 NTG tablets with no relief. His vitals are stable and cardiac enzymes were normal. An ECG on admission is shown. What is the likely diagnosis? (Neet pg 2022)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/29/screenshot-2024-07-29-191548.jpg\" alt=\"\" width=\"500\" height=\"268\"></p>",
      "unique_key": "Q4369885",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731583,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Unstable Angina</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">The patient's presentation includes chest pain unrelieved by nitroglycerin (NTG), stable vitals, and normal cardiac enzymes. The provided ECG is normal, showing no signs of ST elevation or ischemic changes such as ST depression or T wave inversion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Unstable Angina</strong> involves chest pain at rest or with minimal exertion, and normal cardiac enzymes. The patient has multiple risk factors (dyslipidemia, hypertension, aortic sclerosis), and the fact that his chest pain did not respond to NTG and his enzymes are normal strongly suggests unstable angina.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. STEMI: </strong>STEMI is characterized by ST elevation on ECG and elevated cardiac enzymes indicating myocardial necrosis. This patient's ECG shows no ST elevation, and his cardiac enzymes are normal, making STEMI unlikely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. NSTEMI: </strong>NSTEMI would present with elevated cardiac enzymes due to myocardial damage, despite the absence of ST elevation. This patient’s normal enzyme levels exclude NSTEMI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Stable Angina: </strong>Stable angina presents with chest pain that is typically relieved by rest or nitroglycerin. The patient’s chest pain persisted despite taking NTG, indicating that stable angina is not the correct diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Unstable angina is characterized by chest pain that occurs at rest or with minimal exertion, does not respond to nitroglycerin, and is associated with normal cardiac enzyme levels.</span></p>",
      "correct_choice_id": 45373,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58585,
      "choices": [
        {
          "id": 233677,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute Rheumatic Fever</span></p>"
        },
        {
          "id": 233678,
          "text": "<p><span style=\"font-size:12.0pt;\">Seronegative RA</span></p>"
        },
        {
          "id": 233679,
          "text": "<p><span style=\"font-size:12.0pt;\">Ankylosing spondylitis</span></p>"
        },
        {
          "id": 233680,
          "text": "<p><span style=\"font-size:12.0pt;\">Septic arthritis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">18-year-old female presented with high fever and pain in knee and ankle joints. On examination, the patient had a pan-systolic murmur at the apex. Rheumatoid factor is negative. What is the diagnosis? (NEET PG 2024)</span></p>",
      "unique_key": "Q7221119",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731584,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>A) Acute Rheumatic Fever</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presentation of high fever, joint pain (especially in the knee and ankle), and a pan-systolic murmur at the apex suggests mitral regurgitation, which is often seen in acute rheumatic fever. This condition is particularly common among younger individuals and fits within the Jones criteria for acute rheumatic fever, which includes major criteria such as arthritis and carditis, and minor criteria like fever. In this case, the presence of carditis (evidenced by the murmur indicating mitral regurgitation) and arthritis confirms the diagnosis. Acute rheumatic fever commonly leads to valvular damage, primarily affecting the mitral valve, resulting in mitral regurgitation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Seronegative RA:</strong> This option is incorrect because seronegative rheumatoid arthritis is usually a chronic condition that does not present with acute fever or heart murmurs. The patient’s presentation does not fit the typical characteristics of seronegative RA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ankylosing spondylitis:</strong> This is incorrect as ankylosing spondylitis commonly affects the spine and sacroiliac joints and does not usually present with high fever, mitral regurgitation, or the acute onset seen in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Septic arthritis:</strong> This is incorrect because, although septic arthritis can present with joint pain and fever, it would not explain the presence of a pan-systolic murmur or fulfill the criteria for carditis seen in acute rheumatic fever.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acute rheumatic fever is diagnosed when a young patient presents with fever, migratory arthritis, and carditis, often leading to mitral valve involvement, characterized by a murmur indicative of mitral regurgitation.</span></p>",
      "correct_choice_id": 233677,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58585/Neet_Pg_Aug_2024_Medicine_Q_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58585/Neet_Pg_Aug_2024_Medicine_Q_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58586,
      "choices": [
        {
          "id": 233681,
          "text": "<p><span style=\"font-size:12.0pt;\">CCBs are the first line in all patients</span></p>"
        },
        {
          "id": 233682,
          "text": "<p><span style=\"font-size:12.0pt;\">Endothelin antagonists improve symptoms</span></p>"
        },
        {
          "id": 233683,
          "text": "<p><span style=\"font-size:12.0pt;\">Lung transplant is the best treatment if identified early</span></p>"
        },
        {
          "id": 233684,
          "text": "<p><span style=\"font-size:12.0pt;\">Lifestyle modification</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 44-year-old female who is a known case of scleroderma presented with shortness of breath, especially during exercise. She underwent right heart catheterization, and her mean pulmonary artery pressure (mPAP) was 35 mm Hg. Which of the following is true regarding her condition? (NEET PG 2024)</span></p>",
      "unique_key": "Q6847674",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731585,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Endothelin antagonists improve symptoms</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient has pulmonary hypertension associated with scleroderma, specifically type 1 pulmonary arterial hypertension (PAH). The right heart catheterization confirms the diagnosis, which is the gold standard for assessing pulmonary hypertension. In patients with PAH, especially those related to connective tissue diseases like scleroderma, endothelin receptor antagonists (ERAs), such as Bosentan, Ambrisentan, and Macitentan, are commonly used to improve symptoms and enhance the patient's functional status. ERAs work by blocking the effects of endothelin-1, a potent vasoconstrictor, thus reducing pulmonary vascular resistance and improving outcomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. CCBs are the first line in all patients:</strong> Calcium Channel Blockers (CCBs) are not universally used as first-line treatment in all PAH patients. They are only indicated for patients who have a positive response to vasoreactivity testing. For those without a positive response, other targeted therapies, such as endothelin antagonists, phosphodiesterase-5 inhibitors, or prostacyclin analogs, are more appropriate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Lung transplant is the best treatment if identified early:</strong> Although lung transplant may be an option for severe, refractory cases, it is not considered the best treatment due to the complexity and risks associated with the procedure, especially in PAH patients. It is generally reserved for those who fail medical therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Lifestyle modification:</strong> While lifestyle changes can support overall health, they do not directly address the underlying pathophysiology of PAH. Therefore, lifestyle modifications alone are not sufficient as a primary treatment approach for pulmonary hypertension, especially when associated with scleroderma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Endothelin receptor antagonists are effective in improving symptoms and functional status in patients with pulmonary arterial hypertension associated with scleroderma.</span></p>",
      "correct_choice_id": 233682,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58586/Neet_Pg_Aug_2024_Medicine_Q_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58586/Neet_Pg_Aug_2024_Medicine_Q_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58587,
      "choices": [
        {
          "id": 233685,
          "text": "<p><span style=\"font-size:12.0pt;\">Cirrhosis</span></p>"
        },
        {
          "id": 233686,
          "text": "<p><span style=\"font-size:12.0pt;\">Congestive heart failure</span></p>"
        },
        {
          "id": 233687,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural TB</span></p>"
        },
        {
          "id": 233688,
          "text": "<p><span style=\"font-size:12.0pt;\">Nephrotic Syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 44-year-old male presented with cough. Chest X-ray revealed pleural effusion. Thoracentesis was done, and the following was observed. Pleural fluid protein to serum protein ratio was 0.6. Which of the following is the likely diagnosis? (NEET PG 2024)</span></p>",
      "unique_key": "Q5331910",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731586,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>C) Pleural TB</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The pleural fluid protein to serum protein ratio of 0.6 indicates that the pleural effusion is an exudate, as per Light's criteria. Light's criteria state that pleural effusion is classified as an exudate if one or more of the following is true:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Pleural fluid protein/serum protein ratio &gt; 0.5</span></li><li><span style=\"font-size:12.0pt;\">Pleural fluid lactate dehydrogenase (LDH)/serum LDH ratio &gt; 0.6</span></li><li><span style=\"font-size:12.0pt;\">Pleural fluid LDH is more than two-thirds of the upper limit of the normal serum LDH.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this case, since the pleural fluid protein to serum protein ratio is above 0.5, the effusion is classified as exudative. Among the options, the only condition causing exudative effusion is pleural tuberculosis (TB).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cirrhosis:</strong> Pleural effusion in cirrhosis is usually a transudate due to increased hydrostatic pressure or decreased oncotic pressure. It does not meet the criteria for an exudate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. CHF (Congestive Heart Failure):</strong> CHF typically causes transudative pleural effusion due to elevated pulmonary venous pressure, not an exudate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Nephrotic Syndrome:</strong> This condition causes transudative effusions because of low serum albumin levels, resulting in decreased oncotic pressure. It does not fulfill the criteria for an exudate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Exudative pleural effusions, as defined by Light's criteria, are often caused by infections such as pleural TB, malignancy, or inflammatory conditions, while transudative effusions are typically due to systemic factors like cirrhosis, CHF, or nephrotic syndrome.</span></p>",
      "correct_choice_id": 233687,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58587/Neet_Pg_Aug_2024_Medicine_Q_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58587/Neet_Pg_Aug_2024_Medicine_Q_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58588,
      "choices": [
        {
          "id": 233689,
          "text": "<p><span style=\"font-size:12.0pt;\">Celiac disease</span></p>"
        },
        {
          "id": 233690,
          "text": "<p><span style=\"font-size:12.0pt;\">Tropical sprue</span></p>"
        },
        {
          "id": 233691,
          "text": "<p><span style=\"font-size:12.0pt;\">Abetalipoproteinemia</span></p>"
        },
        {
          "id": 233692,
          "text": "<p><span style=\"font-size:12.0pt;\">Whipple disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A mother brought her 2-year-old child to the OPD with complaints of lack of weight gain, abdominal pain on eating, and poor eating habits. The child was advised to follow a gluten-free diet, after which there was an improvement in the general condition and weight gain. What is the probable diagnosis? (NEET PG 2024)</span></p>",
      "unique_key": "Q6672215",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731587,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Celiac disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The child’s symptoms of abdominal pain on eating, poor weight gain, and the significant improvement in condition and weight after adopting a gluten-free diet strongly suggest celiac disease. Celiac disease is an autoimmune disorder where ingestion of gluten leads to damage in the small intestine. The most effective screening test is the anti-TTG IgA test, and the gold standard for diagnosis is endoscopy with biopsy. Although a biopsy is the gold standard, it may overlap with other diseases; however, in the context of a gluten-free diet response, celiac disease is the most probable diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Tropical sprue:</strong> Tropical sprue is typically seen in individuals living in tropical regions and is often considered a diagnosis of exclusion. It presents with symptoms similar to celiac disease but usually involves vitamin B12 deficiency and does not respond specifically to a gluten-free diet.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Abetalipoproteinemia:</strong> Abetalipoproteinemia is a rare genetic disorder characterized by neurological symptoms, growth retardation, and vitamin deficiencies such as vitamin A deficiency causing night blindness. Patients may have characteristic acanthocytes on a blood smear, which is not seen in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Whipple disease:</strong> Whipple disease is a rare bacterial infection that presents with more complex symptoms such as dementia, cardiac involvement, and gastrointestinal disturbances. The patient does not display the classic symptoms of Whipple disease, such as dementia or cardiac issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Celiac disease should be suspected in patients with symptoms of gastrointestinal distress, poor weight gain, and improvement upon adopting a gluten-free diet.</span></p>",
      "correct_choice_id": 233689,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58588/Neet_Pg_Aug_2024_Medicine_Q_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58588/Neet_Pg_Aug_2024_Medicine_Q_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58592,
      "choices": [
        {
          "id": 233705,
          "text": "<p><span style=\"font-size:12.0pt;\">IVIg</span></p>"
        },
        {
          "id": 233706,
          "text": "<p><span style=\"font-size:12.0pt;\">Doxorubicin + epirubicin</span></p>"
        },
        {
          "id": 233707,
          "text": "<p><span style=\"font-size:12.0pt;\">Radiotherapy to the lymph node</span></p>"
        },
        {
          "id": 233708,
          "text": "<p><span style=\"font-size:12.0pt;\">Prednisolone + Vincristine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 7-year-old child presented with fatigue. On examination, there were scattered purpuric rashes, and abdominal examination was notable for cervical lymphadenopathy and hepato-splenomegaly. Lab parameters are shown – Hb 7 g/dL, WBC 50,000, platelets 60,000. What is the treatment? (NEET PG 2024)</span></p>",
      "unique_key": "Q5321332",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731588,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Prednisolone + Vincristine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation of the patient, including fatigue, scattered purpuric rashes, cervical lymphadenopathy, hepatosplenomegaly, anemia (Hb 7 g/dL), leukocytosis (WBC 50,000), and thrombocytopenia (platelets 60,000), suggests a diagnosis of Acute Lymphoblastic Leukemia (ALL). ALL is the most common type of cancer in children, characterized by the proliferation of immature lymphoid cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The standard treatment regimen for ALL typically includes induction chemotherapy with a combination of drugs that form the backbone of therapy. Prednisolone (a corticosteroid) and Vincristine (a vinca alkaloid) are integral components of this induction regimen. Prednisolone helps reduce inflammation and immune response, while Vincristine disrupts microtubule formation in cells, effectively halting cell division. These two drugs are part of the standard first-line treatment to induce remission in ALL patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. IVIg:</strong> Intravenous immunoglobulin (IVIg) is used to boost the immune system in conditions such as immune deficiencies or autoimmune diseases but does not treat ALL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Doxorubicin + epirubicin:</strong> These are anthracyclines used in certain cancers like breast cancer, lymphomas, and some leukemias. However, this combination is not the first-line treatment for ALL and does not replace the standard induction regimen of ALL involving corticosteroids and vinca alkaloids.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Radiotherapy to the lymph node:</strong> Radiotherapy is not a standard first-line treatment for ALL. It may be used in specific cases, such as in T-cell ALL with mediastinal mass or CNS involvement, but it is not used for initial induction therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The core treatment regimen for ALL includes Prednisolone and Vincristine as part of the induction chemotherapy to induce remission in pediatric patients.</span></p>",
      "correct_choice_id": 233708,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58592/Neet_Pg_Aug_2024_Medicine_Q_21.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58592/Neet_Pg_Aug_2024_Medicine_Q_21.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58593,
      "choices": [
        {
          "id": 233709,
          "text": "<p><span style=\"font-size:12.0pt;\">HOCM (Hypertrophic Obstructive Cardiomyopathy)</span></p>"
        },
        {
          "id": 233710,
          "text": "<p><span style=\"font-size:12.0pt;\">RHD (Rheumatic Heart Disease)</span></p>"
        },
        {
          "id": 233711,
          "text": "<p><span style=\"font-size:12.0pt;\">CAD (Coronary Artery Disease)</span></p>"
        },
        {
          "id": 233712,
          "text": "<p><span style=\"font-size:12.0pt;\">DCM (Dilated Cardiomyopathy)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 29-year-old athlete suddenly collapsed and died during a sports activity. Autopsy was done, and cardiac biopsy was shown. What is the likely diagnosis? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/25/screenshot-2024-09-25-125242.jpg\" alt=\"\" width=\"400\" height=\"304\"></span></p>",
      "unique_key": "Q7420756",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731589,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) HOCM (Hypertrophic Obstructive Cardiomyopathy)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hypertrophic Obstructive Cardiomyopathy (HOCM) is the most common cause of sudden cardiac death in young athletes. It is characterized by abnormal thickening of the heart muscle, particularly the interventricular septum, which can obstruct blood flow and lead to life-threatening arrhythmias.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The cardiac biopsy from this case shows myocyte disarray, myocyte hypertrophy, and interstitial fibrosis—key histological features of HOCM. Myocyte disarray, often referred to as \"helter-skelter\" myocyte disarray, is highly indicative of HOCM. This disarray leads to inefficient cardiac muscle contraction and electrical disturbances, contributing to sudden death during exertion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. RHD (Rheumatic Heart Disease):</strong> RHD primarily affects the heart valves due to immune-mediated damage following streptococcal infection. It typically presents with valve abnormalities rather than sudden cardiac collapse due to muscle disarray. It does not cause the histological features observed in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. CAD (Coronary Artery Disease):</strong> CAD involves narrowing of the coronary arteries due to plaque buildup, leading to myocardial infarction. While CAD can cause sudden death, it is less common in young athletes, and biopsy findings would show ischemic damage, not myocyte disarray.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. DCM (Dilated Cardiomyopathy):</strong> DCM involves dilation and impaired contraction of the ventricles, leading to heart failure. Histologically, DCM would show dilated chambers and fibrotic changes rather than myocyte disarray and hypertrophy seen in HOCM.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">HOCM is the leading cause of sudden cardiac death in young athletes. Key histological features include myocyte hypertrophy, interstitial fibrosis, and myocyte disarray, which should be promptly recognized in clinical and autopsy settings.</span></p>",
      "correct_choice_id": 233709,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58593/Neet_Pg_Aug_2024_Medicine_Q_22.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58593/Neet_Pg_Aug_2024_Medicine_Q_22.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58594,
      "choices": [
        {
          "id": 233713,
          "text": "<p><span style=\"font-size:12.0pt;\">PML-RARA</span></p>"
        },
        {
          "id": 233714,
          "text": "<p><span style=\"font-size:12.0pt;\">BCR-ABL</span></p>"
        },
        {
          "id": 233715,
          "text": "<p><span style=\"font-size:12.0pt;\">MYC-IgH</span></p>"
        },
        {
          "id": 233716,
          "text": "<p><span style=\"font-size:12.0pt;\">DEK-MUP4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presented with recurrent nasal bleeding. On examination, there was hepatosplenomegaly and WBC count is 40,000. Her peripheral smear is shown. On further evaluation, her PT, aPTT, and D-dimer were elevated. Which of the following cytogenetic changes is likely to be seen? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/25/screenshot-2024-09-25-125257.jpg\" alt=\"\" width=\"400\" height=\"300\"></span></p>",
      "unique_key": "Q6724380",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731590,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) PML-RARA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The child’s presentation with recurrent nasal bleeding, hepatosplenomegaly, and an elevated WBC count suggests a hematological malignancy. The peripheral smear shows blasts with prominent nucleoli, a lower nucleus-to-cytoplasm (NC) ratio, granularity, and the presence of Auer rods, characteristic of acute promyelocytic leukemia (APL). The presence of Disseminated Intravascular Coagulation (DIC), as indicated by elevated PT, aPTT, and D-dimer levels, further supports this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acute promyelocytic leukemia (APL), formerly known as AML-M3, is most commonly associated with the t(15;17) translocation, which leads to the formation of the PML-RARA fusion gene. This genetic abnormality disrupts the differentiation of myeloid cells, leading to the accumulation of promyelocytes. The characteristic cytogenetic change in APL is PML-RARA, and the treatment involves all-trans-retinoic acid (ATRA) and arsenic trioxide.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. BCR-ABL:</strong> This translocation (Philadelphia chromosome) is characteristic of chronic myeloid leukemia (CML), not APL. CML typically presents with elevated WBCs, but not with the DIC pattern seen in APL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. MYC-IgH:</strong> This translocation is associated with Burkitt lymphoma, a B-cell malignancy. It does not present with Auer rods or DIC and is not related to myeloid leukemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. DEK-MUP4:</strong> This rare fusion gene is associated with a different subtype of acute myeloid leukemia (AML) but does not typically present with DIC or Auer rods, making it an unlikely diagnosis for this clinical scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acute promyelocytic leukemia (APL) is characterized by the t(15;17) translocation, which leads to the PML-RARA fusion gene. It commonly presents with DIC and is identified by the presence of Auer rods on the peripheral smear.</span></p>",
      "correct_choice_id": 233713,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58594/Neet_Pg_Aug_2024_Medicine_Q_23.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58594/Neet_Pg_Aug_2024_Medicine_Q_23.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58595,
      "choices": [
        {
          "id": 233717,
          "text": "<p><span style=\"font-size:12.0pt;\">SACD due to Vitamin B12 deficiency</span></p>"
        },
        {
          "id": 233718,
          "text": "<p><span style=\"font-size:12.0pt;\">SACD due to Diabetes</span></p>"
        },
        {
          "id": 233719,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple myeloma</span></p>"
        },
        {
          "id": 233720,
          "text": "<p><span style=\"font-size:12.0pt;\">Alcoholic neuropathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">57-year-old male presented with polyuria, weight loss, and tingling sensation in the lower limbs. Bone marrow biopsy is shown. What is the likely diagnosis? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/25/screenshot-2024-09-25-125318.jpg\" alt=\"\" width=\"400\" height=\"323\"></span></p>",
      "unique_key": "Q6980730",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731591,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>C) Multiple myeloma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The bone marrow biopsy shows a large number of malignant plasma cells, some of which have characteristic vacuolations and the presence of Dutcher bodies and Mott cells, which are indicative of multiple myeloma. Multiple myeloma is a cancer of plasma cells that can cause various systemic symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Clinical Correlation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Polyuria:</strong> This can occur due to hypercalcemia, which is common in multiple myeloma due to bone resorption caused by the malignant plasma cells.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Weight Loss:</strong> As a cancer, multiple myeloma often leads to significant weight loss due to increased metabolic demands and tumor burden.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Tingling Sensation in Lower Limbs:</strong> This symptom is likely due to peripheral neuropathy, which can be caused by amyloidosis (a common complication of multiple myeloma) or by the direct effects of excessive light chain production in multiple myeloma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. SACD due to Vitamin B12 deficiency:</strong> Subacute combined degeneration (SACD) due to Vitamin B12 deficiency typically presents with neurological symptoms such as tingling or numbness, but it is usually associated with anemia, ataxia, and specific spinal cord changes, not malignant plasma cells in the bone marrow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. SACD due to Diabetes:</strong> While diabetes can cause peripheral neuropathy, it does not cause malignant plasma cell infiltration in the bone marrow, polyuria due to hypercalcemia, or weight loss related to cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Alcoholic neuropathy:</strong> This condition causes peripheral neuropathy due to chronic alcohol use, but it does not fit the overall presentation of malignant plasma cells, hypercalcemia, and systemic cancer symptoms seen in multiple myeloma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Multiple myeloma presents with malignant plasma cells in the bone marrow, systemic symptoms like polyuria due to hypercalcemia, weight loss, and peripheral neuropathy.</span></p>",
      "correct_choice_id": 233719,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58595/Neet_Pg_Aug_2024_Medicine_Q_24.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58595/Neet_Pg_Aug_2024_Medicine_Q_24.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58596,
      "choices": [
        {
          "id": 233721,
          "text": "<p><span style=\"font-size:12.0pt;\">46XY t(9;22)</span></p>"
        },
        {
          "id": 233722,
          "text": "<p><span style=\"font-size:12.0pt;\">47 XY +21</span></p>"
        },
        {
          "id": 233723,
          "text": "<p><span style=\"font-size:12.0pt;\">45XY t(14;21)</span></p>"
        },
        {
          "id": 233724,
          "text": "<p><span style=\"font-size:12.0pt;\">46XY SRY gene deletion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old patient presented with fatigue. Labs are as follows - Hb 8 g/dL, WBC 150,000, and platelets 50,000. Examination is significant for hepatosplenomegaly. Bone marrow biopsy is shown. What is the most common karyotypic abnormality? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/25/screenshot-2024-09-25-125334.jpg\" alt=\"\" width=\"400\" height=\"448\"></span></p>",
      "unique_key": "Q7553915",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731592,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>A) 46XY t(9;22)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's presentation, including significant anemia, leukocytosis, thrombocytopenia, and hepatosplenomegaly, along with the bone marrow biopsy showing blasts with a high nucleus-to-cytoplasm (NC) ratio, scant agranular cytoplasm, and clear cytoplasm, is suggestive of acute lymphoblastic leukemia (ALL).</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Philadelphia Chromosome (t(9;22))</strong>: The most common karyotypic abnormality in adults with ALL is the Philadelphia chromosome, which results from the translocation between chromosomes 9 and 22, leading to the formation of the BCR-ABL fusion gene. This mutation is associated with a more aggressive form of ALL and is commonly seen in adult patients.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Cytogenetic Characteristics</strong>: The presence of t(9;22) is associated with poor prognosis and requires targeted therapy with tyrosine kinase inhibitors in addition to standard chemotherapy.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 47 XY +21</strong>: This karyotype is seen in Down syndrome, which is associated with an increased risk of ALL, but it is not the most common cytogenetic abnormality in adult ALL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 45XY t(14;21)</strong>: This translocation is not associated with ALL</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 46XY SRY gene deletion</strong>: This option does not relate to ALL</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most common cytogenetic abnormality in adult acute lymphoblastic leukemia (ALL) is the Philadelphia chromosome, characterized by the t(9;22) translocation leading to the BCR-ABL fusion gene.</span></p>",
      "correct_choice_id": 233721,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58596/Neet_Pg_Aug_2024_Medicine_Q_25.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58596/Neet_Pg_Aug_2024_Medicine_Q_25.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58597,
      "choices": [
        {
          "id": 233725,
          "text": "<p><span style=\"font-size:12.0pt;\">Dengue</span></p>"
        },
        {
          "id": 233726,
          "text": "<p><span style=\"font-size:12.0pt;\">Leptospirosis</span></p>"
        },
        {
          "id": 233727,
          "text": "<p><span style=\"font-size:12.0pt;\">Malaria</span></p>"
        },
        {
          "id": 233728,
          "text": "<p><span style=\"font-size:12.0pt;\">Anthrax</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 44-year-old farmer presented with fever, retro-orbital pain, and calf pain. On examination, he has conjunctival suffusion. Lab reports revealed that the patient likely has jaundice and renal failure. What is the likely diagnosis? (NEET PG 2024)</span></p>",
      "unique_key": "Q1610259",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731593,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>B) Leptospirosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Leptospirosis is a bacterial infection commonly seen in individuals with occupational exposure to contaminated water or animals, such as farmers. The disease is characterized by fever, muscle pain (especially calf pain), and conjunctival suffusion (reddening of the eyes without discharge). The combination of these symptoms, along with jaundice and renal involvement (renal failure), strongly suggests leptospirosis. Conjunctival suffusion and calf pain are hallmark signs of the disease, distinguishing it from other conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Dengue:</strong> Dengue typically presents with high fever, severe headache, retro-orbital pain, and muscle and joint pain. However, it does not cause calf pain specifically, nor is conjunctival suffusion a feature. Additionally, dengue is less likely to be associated with renal failure and jaundice, making it an unlikely diagnosis here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Malaria:</strong> Malaria presents with cyclical fever, chills, and sweating, along with symptoms like headache and muscle pain. However, conjunctival suffusion and specific calf pain are not characteristic features of malaria. Jaundice can occur, but renal failure and the other distinct symptoms of leptospirosis make this diagnosis less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Anthrax:</strong> Anthrax can present with fever and muscle pain, but it is typically associated with cutaneous lesions, respiratory symptoms, or gastrointestinal issues, depending on the type of exposure. Conjunctival suffusion and calf pain are not common features of anthrax, making it the incorrect diagnosis in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Leptospirosis should be considered in patients presenting with fever, conjunctival suffusion, and specific muscle pain (especially calf pain), particularly in those with occupational risks like farming.</span></p>",
      "correct_choice_id": 233726,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58597/Neet_Pg_Aug_2024_Medicine_Q_26.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58597/Neet_Pg_Aug_2024_Medicine_Q_26.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58598,
      "choices": [
        {
          "id": 233729,
          "text": "<p><span style=\"font-size:12.0pt;\">Artesunate 50 mg (4 tablets) + Primaquine 2.5 mg (6 tablets)</span></p>"
        },
        {
          "id": 233730,
          "text": "<p><span style=\"font-size:12.0pt;\">Artesunate 50 mg (4 tablets) + Primaquine 7.5 mg (6 tablets)</span></p>"
        },
        {
          "id": 233731,
          "text": "<p><span style=\"font-size:12.0pt;\">Artesunate 50 mg (4 tablets) + Sulfadoxine/pyrimethamine (750/25 tablets) + Primaquine 2.5 mg (6 tablets)</span></p>"
        },
        {
          "id": 233732,
          "text": "<p><span style=\"font-size:12.0pt;\">Artesunate 50 mg (4 tablets) + Sulfadoxine/pyrimethamine (750/25 tablets) + Primaquine 7.5 mg (6 tablets)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 18-year-old boy from Rajasthan weighing 50 kg is diagnosed with mixed P. vivax and P. falciparum malaria. What is the appropriate treatment regimen on day 2? (NEET PG 2024)</span></p>",
      "unique_key": "Q8016352",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731594,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Artesunate 50 mg (4 tablets) + Primaquine 2.5 mg (6 tablets)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the treatment of malaria, the choice of drugs and regimen depends on the type of malaria (whether it's <i>P. vivax</i>, <i>P. falciparum</i>, or mixed infection) and the geographic location due to different strains' drug resistance profiles. For mixed infections involving <i>P. vivax</i> and <i>P. falciparum</i>, the treatment typically includes a combination of drugs targeting both species.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For <i>P. vivax</i> malaria, chloroquine is generally used, followed by primaquine for 14 days to achieve a radical cure by eliminating hypnozoites and preventing relapse. However, in mixed infections and <i>P. falciparum</i> malaria, the treatment regimen includes an Artemisinin-based Combination Therapy (ACT). Specifically, in regions like Rajasthan, ACT comprises artesunate plus sulfadoxine/pyrimethamine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">On day 2 of treatment, sulfadoxine/pyrimethamine (which is given only on day 1) has already been administered, so the treatment continues with artesunate and primaquine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Primaquine is dosed at 0.25 mg/kg for 14 days in cases of <i>P. vivax</i>, and the dosage calculated for this patient (weighing 50 kg) is 15 mg/day</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">(0.25 mg/kg × 50 kg = 12.5 mg, rounded to the nearest available tablet strength).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct regimen on day 2 includes <strong>Artesunate</strong> (to continue targeting the malaria parasites) and <strong>Primaquine</strong> (for radical cure and to prevent relapse), specifically at the dosage of 2.5 mg per tablet (6 tablets totaling 15 mg).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Malaria Treatment Regimens:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/12/screenshot-2024-10-12-122003.jpg\" alt=\"\" width=\"1000\" height=\"496\"></strong></span></p>",
      "correct_choice_id": 233729,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58598/Neet_Pg_Aug_2024_Medicine_Q_27.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58598/Neet_Pg_Aug_2024_Medicine_Q_27.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11623,
      "choices": [
        {
          "id": 46458,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitamin D toxicity</span></span></span></p>"
        },
        {
          "id": 46459,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute pancreatitis</span></span></span></p>"
        },
        {
          "id": 46460,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chronic kidney disease</span></span></span></p>"
        },
        {
          "id": 46461,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypoparathyroidism</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient presents with perioral numbness, tingling, and tetany. All the following conditions can lead to this, except:</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
      "unique_key": "Q9862231",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731595,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Vitamin D toxicity</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Vitamin D toxicity&nbsp;</span></strong><span style=\"font-size:12.0pt\">leads to <strong>hypercalcemia</strong>, not hypocalcemia. Excessive vitamin D increases calcium absorption from the gastrointestinal tract and mobilizes calcium from bones, leading to elevated serum calcium levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Perioral numbness, tingling, and tetany are symptoms indicative of hypocalcemia. Various conditions can lead to hypocalcemia, each through different mechanisms:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Acute Pancreatitis</span></strong><span style=\"font-size:12.0pt\">: This condition can lead to hypocalcemia due to the sequestration of calcium in the inflamed pancreatic tissue and the formation of calcium soaps.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Chronic Kidney Disease</span></strong><span style=\"font-size:12.0pt\">: CKD results in hypocalcemia primarily due to decreased production of calcitriol (active vitamin D). The kidneys are unable to convert 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D, leading to decreased calcium absorption in the gut.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hypoparathyroidism</span></strong><span style=\"font-size:12.0pt\">: This condition, often resulting from surgical removal or damage to the parathyroid glands, leads to decreased production of parathyroid hormone (PTH). PTH is crucial for calcium homeostasis, and its deficiency results in hypocalcemia. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitamin D toxicity causes hypercalcemia, not hypocalcemia, distinguishing it from other conditions that can lead to hypocalcemia.</span></span></span></p>",
      "correct_choice_id": 46458,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12008,
      "choices": [
        {
          "id": 47996,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Brown-Sequard syndrome</span></span></span></p>"
        },
        {
          "id": 47997,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tabes dorsalis</span></span></span></p>"
        },
        {
          "id": 47998,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Syringobulbia</span></span></span></p>"
        },
        {
          "id": 47999,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Syringomyelia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A female presented with loss of pain and temperature, but her touch sensation was intact. Imaging showed cavitation around the central canal. What is the probable diagnosis? (INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q5407363",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731596,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. </span></strong><span style=\"font-size:12.0pt\">&nbsp;<strong>D) Syringomyelia</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Syringomyelia is characterized by the presence of a fluid-filled cavity or syrinx within the spinal cord, which typically expands over time. This condition most commonly affects the cervical and thoracic regions of the spinal cord. The classic presentation includes a loss of pain and temperature sensation in a &quot;cape-like&quot; distribution over the shoulders and back, while touch, vibration, and proprioception (posterior column sensations) remain intact. This pattern of sensory loss is due to the disruption of the decussating (crossing) fibers of the spinothalamic tract, which carry pain and temperature sensations. The cavitation around the central canal of the spinal cord is a hallmark of syringomyelia and leads to the aforementioned symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Brown-Sequard syndrome: </span></strong><span style=\"font-size:12.0pt\">This condition results from hemisection or damage to one half of the spinal cord. It typically presents with ipsilateral motor loss and loss of proprioception and vibration sense, and contralateral loss of pain and temperature sensation below the level of the lesion. This does not match the described symptoms and imaging findings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Tabes dorsalis: </span></strong><span style=\"font-size:12.0pt\">This is a late manifestation of neurosyphilis, characterized by degeneration of the dorsal columns of the spinal cord, leading to impaired proprioception and vibration sense, ataxia, and lightning pains. It does not cause cavitation around the central canal or the specific dissociated sensory loss seen in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Syringobulbia: </span></strong><span style=\"font-size:12.0pt\">This is a similar condition to syringomyelia but involves the brainstem (medulla oblongata) rather than the spinal cord. It presents with symptoms related to cranial nerve involvement such as dysphagia, dysarthria, and facial pain. The patient&#39;s symptoms and imaging findings are more consistent with syringomyelia, not syringobulbia</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Syringomyelia presents with a loss of pain and temperature sensation while preserving touch sensation, and is characterized by cavitation around the central canal of the spinal cord.</span></span></span></p>",
      "correct_choice_id": 47999,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58599,
      "choices": [
        {
          "id": 233733,
          "text": "<p><span style=\"font-size:12.0pt;\">Abetalipoproteinemia</span></p>"
        },
        {
          "id": 233734,
          "text": "<p><span style=\"font-size:12.0pt;\">EDTA changes</span></p>"
        },
        {
          "id": 233735,
          "text": "<p><span style=\"font-size:12.0pt;\">Uremia</span></p>"
        },
        {
          "id": 233736,
          "text": "<p><span style=\"font-size:12.0pt;\">Burns</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 20-year-old male presented with diarrhea, visual symptoms, and neurological manifestations. Based on the peripheral smear finding, what is the likely diagnosis? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/25/screenshot-2024-09-25-125400.jpg\" alt=\"\" width=\"400\" height=\"322\"></span></p>",
      "unique_key": "Q1292996",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731597,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Abetalipoproteinemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The peripheral smear in this case shows acanthocytes, which are red blood cells with irregular projections. Acanthocytes are a hallmark finding in abetalipoproteinemia, a rare inherited disorder caused by a mutation in the Microsomal Triglyceride Transfer Protein (MTTP) gene. This mutation leads to defective absorption of fat-soluble vitamins (A, D, E, K) and lipids, which are essential for normal cellular function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In abetalipoproteinemia, patients often present with:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Diarrhea</strong>: Due to malabsorption of fats, leading to steatorrhea (fatty stools).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Visual symptoms</strong>: Resulting from vitamin A deficiency, which affects vision.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Neurological symptoms</strong>: Caused by deficiencies in vitamins A and E, affecting nerve function.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. EDTA changes</strong>: EDTA is an anticoagulant used in blood sample collection. It can cause artifacts in peripheral blood smears, but these changes do not present with systemic symptoms like diarrhea, visual disturbances, and neurological signs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Uremia</strong>: Uremia can cause red blood cell morphological changes like burr cells (echinocytes) due to kidney failure. However, it does not cause acanthocytes and does not present with diarrhea, visual, or neurological symptoms seen in abetalipoproteinemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Burns</strong>: Severe burns can also lead to the formation of burr cells or echinocytes on a peripheral smear. However, the clinical presentation and peripheral smear findings described are not consistent with burns.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Abetalipoproteinemia is characterized by acanthocytes on the peripheral smear and presents with diarrhea, visual symptoms, and neurological manifestations due to fat-soluble vitamin deficiencies<strong>.</strong></span></p>",
      "correct_choice_id": 233733,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58599/Neet_Pg_Aug_2024_Medicine_Q_28.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58599/Neet_Pg_Aug_2024_Medicine_Q_28.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58600,
      "choices": [
        {
          "id": 233737,
          "text": "<p><span style=\"font-size:12.0pt;\">i, ii, iii, iv</span></p>"
        },
        {
          "id": 233738,
          "text": "<p><span style=\"font-size:12.0pt;\">ii, i, iii, iv</span></p>"
        },
        {
          "id": 233739,
          "text": "<p><span style=\"font-size:12.0pt;\">iv, iii, ii, i</span></p>"
        },
        {
          "id": 233740,
          "text": "<p><span style=\"font-size:12.0pt;\">ii, i, iv, iii</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Arrange the ECGs in order: Atrial flutter, Atrial fibrillation, PSVT, and Ventricular Tachycardia. (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/25/screenshot-2024-09-25-125433.jpg\" alt=\"\" width=\"400\" height=\"472\"></span></p>",
      "unique_key": "Q3218319",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731598,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>B) ii, i, iii, iv</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct order of the ECGs based on the arrhythmias provided is:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Atrial fibrillation (i):</strong> This ECG shows the classic irregularly irregular rhythm with no distinct P waves, characteristic of atrial fibrillation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Atrial flutter (ii):</strong> This ECG displays a sawtooth pattern of atrial activity, which is indicative of atrial flutter. This appearance is due to the rapid, regular atrial contractions.</span></li><li><span style=\"font-size:12.0pt;\"><strong>PSVT (iii):</strong> Paroxysmal Supraventricular Tachycardia (PSVT) is represented by a narrow complex tachycardia without discernible P waves, often seen in reentrant tachycardias like AVNRT (Atrioventricular Nodal Reentrant Tachycardia).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Ventricular Tachycardia (VTACH) (iv):</strong> The final ECG shows a monomorphic ventricular tachycardia, characterized by wide QRS complexes and a regular, rapid rhythm.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">&nbsp;Recognize key ECG patterns such as the sawtooth wave for atrial flutter, irregularly irregular rhythm for atrial fibrillation, narrow complex tachycardia for PSVT, and wide QRS complexes for ventricular tachycardia.</span></p>",
      "correct_choice_id": 233738,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58600/Neet_Pg_Aug_2024_Medicine_Q_29.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58600/Neet_Pg_Aug_2024_Medicine_Q_29.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58601,
      "choices": [
        {
          "id": 233741,
          "text": "<p><span style=\"font-size:12.0pt;\">Burkitt’s lymphoma</span></p>"
        },
        {
          "id": 233742,
          "text": "<p><span style=\"font-size:12.0pt;\">DLBCL (Diffuse Large B-Cell Lymphoma)</span></p>"
        },
        {
          "id": 233743,
          "text": "<p><span style=\"font-size:12.0pt;\">ALCL (Anaplastic Large Cell Lymphoma)</span></p>"
        },
        {
          "id": 233744,
          "text": "<p><span style=\"font-size:12.0pt;\">ALL (Acute Lymphoblastic Leukemia)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 12-year-old child presented with cervical lymphadenopathy. A biopsy is obtained and it is as shown below. Flow cytometry showed the following findings: Tdt – negative, CD5/CD23 – negative, CD10/CD19/CD20, and SIg are positive. What is the likely diagnosis? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/25/screenshot-2024-09-25-125456.jpg\" alt=\"\" width=\"400\" height=\"303\"></span></p>",
      "unique_key": "Q3918069",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731599,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Burkitt’s lymphoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The biopsy and flow cytometry findings are consistent with Burkitt’s lymphoma, which is a high-grade B-cell lymphoma commonly seen in children and young adults. The characteristic features include negative Tdt, negative CD5, and CD23, with positive CD10, CD19, CD20, and surface immunoglobulin (SIg). The biopsy often shows a \"starry sky\" appearance due to macrophages with ingested apoptotic cells. These findings, along with the age and presentation, strongly suggest Burkitt’s lymphoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. DLBCL (Diffuse Large B-Cell Lymphoma):</strong> DLBCL is more common in adults and typically presents as a rapidly growing mass, but it is not commonly seen in young children like this patient. Flow cytometry findings do not specifically point to DLBCL, making it a less likely diagnosis in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. ALCL (Anaplastic Large Cell Lymphoma):</strong> ALCL is usually characterized by ALK positivity and CD30 positivity. The absence of ALK and CD30 markers, which are key for diagnosing ALCL, rules this option out.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. ALL (Acute Lymphoblastic Leukemia):</strong> ALL is ruled out primarily due to the negative Tdt, a marker typically positive in ALL. Additionally, ALL would present with different immunophenotypic markers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Burkitt’s lymphoma should be considered in young patients presenting with cervical lymphadenopathy and specific flow cytometry findings including negative Tdt and positive CD10, CD19, CD20, and SIg.</span></p>",
      "correct_choice_id": 233741,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58601/Neet_Pg_Aug_2024_Medicine_Q_30.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58601/Neet_Pg_Aug_2024_Medicine_Q_30.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58602,
      "choices": [
        {
          "id": 233745,
          "text": "<p><span style=\"font-size:12.0pt;\">It can lead to vision loss</span></p>"
        },
        {
          "id": 233746,
          "text": "<p><span style=\"font-size:12.0pt;\">Response to vision symptoms is adjuvant to thyrotoxicosis response</span></p>"
        },
        {
          "id": 233747,
          "text": "<p><span style=\"font-size:12.0pt;\">NOSPECS classification is used</span></p>"
        },
        {
          "id": 233748,
          "text": "<p><span style=\"font-size:12.0pt;\">10% of euthyroid patients can have eye involvement.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is false in patients with thyroid eye disease? (NEET PG 2024)</span></p>",
      "unique_key": "Q8763231",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731600,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Response to vision symptoms is adjuvant to thyrotoxicosis response</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thyroid eye disease (TED), also known as Graves' ophthalmopathy, is an autoimmune disorder associated with thyroid dysfunction, most commonly Graves' disease. TED can cause significant eye symptoms independent of thyroid hormone levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B is false because the treatment for vision symptoms in thyroid eye disease is separate from the management of thyrotoxicosis.</strong> While controlling thyroid hormone levels is important, the eye manifestations are managed based on the severity of the eye disease. For mild to moderate cases, supportive care, including selenium supplementation, may be helpful. For moderate to severe cases, corticosteroids like dexamethasone or prednisolone are often used, and newer treatments like teprotumumab, an anti-IGF-1 receptor blocker, can be highly effective. Therefore, the response to eye symptoms does not directly correlate with the response to thyroid hormone management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. It can lead to vision loss:</strong> This statement is true. Thyroid eye disease can lead to severe complications, including vision loss due to optic nerve compression or severe corneal exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. NOSPECS classification is used:</strong> This is correct. The NOSPECS classification system is used to grade the severity of thyroid eye disease, evaluating factors like soft tissue involvement, proptosis, and corneal involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 10% of euthyroid patients can have eye involvement:</strong> This is true. Eye involvement in thyroid eye disease can occur even in the absence of abnormal thyroid function tests, a condition referred to as \"euthyroid Graves' disease.\"</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The treatment of vision symptoms in thyroid eye disease is distinct and not directly tied to the management of thyrotoxicosis, highlighting the need for tailored therapy based on the eye disease severity.</span></p>",
      "correct_choice_id": 233746,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58602/Neet_Pg_Aug_2024_Medicine_Q_31.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "CriteriaBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58602/Neet_Pg_Aug_2024_Medicine_Q_31.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58604,
      "choices": [
        {
          "id": 233753,
          "text": "<p><span style=\"font-size:12.0pt;\">Rifampicin resistance with katG and inhA mutations</span></p>"
        },
        {
          "id": 233754,
          "text": "<p><span style=\"font-size:12.0pt;\">Extrapulmonary TB with hydrocephalus</span></p>"
        },
        {
          "id": 233755,
          "text": "<p><span style=\"font-size:12.0pt;\">Rifampicin resistant but FQ sensitive TB</span></p>"
        },
        {
          "id": 233756,
          "text": "<p><span style=\"font-size:12.0pt;\">Rifampicin sensitive TB</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is an indication for short-course bedaquiline-containing regimen in the treatment of tuberculosis? (NEET PG 2024)</span></p>",
      "unique_key": "Q5177954",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731601,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Rifampicin resistant but FQ sensitive TB</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Short-course bedaquiline-containing regimens are used in the management of multidrug-resistant tuberculosis (MDR-TB). The inclusion criteria for this regimen specifically allow for patients with rifampicin-resistant TB, but they should be sensitive to fluoroquinolones (FQs). This combination allows the regimen to effectively target the resistant Mycobacterium tuberculosis while utilizing other potent drugs, including bedaquiline.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Option C directly matches these criteria, indicating a rifampicin-resistant but fluoroquinolone-sensitive TB case, making it a standard indication for the short-course bedaquiline-containing MDR regimen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Rifampicin resistance with katG and inhA mutations:</strong> This option is incorrect because the presence of both katG and inhA mutations indicates high-level isoniazid resistance, which is an exclusion criterion for the short-course bedaquiline-containing regimen. Only one of these mutations, not both, should be present to be considered for this regimen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Extrapulmonary TB with hydrocephalus:</strong> Severe forms of TB, including extrapulmonary TB with complications such as hydrocephalus, are excluded from short-course regimens. These cases often require individualized treatment plans due to the complexity and severity of the disease, thus excluding the use of the standard MDR regimen containing bedaquiline.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Rifampicin sensitive TB:</strong> Rifampicin-sensitive TB does not require an MDR regimen since standard first-line drugs (HRZE: Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol) are effective. The use of bedaquiline-containing regimens is unnecessary and not indicated for such cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The short-course bedaquiline-containing regimen is indicated for patients with rifampicin-resistant but fluoroquinolone-sensitive TB. Understanding the inclusion and exclusion criteria is crucial for the appropriate management of MDR-TB.</span></p>",
      "correct_choice_id": 233755,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58604/Neet_Pg_Aug_2024_Medicine_Q_32.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "CriteriaBased",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58604/Neet_Pg_Aug_2024_Medicine_Q_32.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58606,
      "choices": [
        {
          "id": 233761,
          "text": "<p><span style=\"font-size:12.0pt;\">Bortezomib</span></p>"
        },
        {
          "id": 233762,
          "text": "<p><span style=\"font-size:12.0pt;\">Lenalidomide</span></p>"
        },
        {
          "id": 233763,
          "text": "<p><span style=\"font-size:12.0pt;\">Daratumumab</span></p>"
        },
        {
          "id": 233764,
          "text": "<p><span style=\"font-size:12.0pt;\">Melphalan</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old patient presents with symptoms of bone pain, anemia, hypercalcemia, and renal impairment. Subsequent bone marrow biopsy confirms multiple myeloma and treatment was initiated. Which of the following is most likely associated with the reactivation of herpes zoster? (NEET PG 2024)</span></p>",
      "unique_key": "Q6928638",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731602,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Bortezomib</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bortezomib is a proteasome inhibitor used in the treatment of multiple myeloma. It is known to increase the risk of reactivation of herpes zoster (shingles) in patients undergoing treatment. This occurs because bortezomib can impair immune function, particularly cellular immunity, which plays a crucial role in controlling latent viral infections such as herpes zoster.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">To prevent this reactivation, standard prophylaxis with antiviral medications like acyclovir is recommended during bortezomib treatment. The typical prophylactic dose is 400 mg of acyclovir once daily. Despite its efficacy in treating multiple myeloma, careful monitoring and preventive measures are essential to manage its side effects, including the risk of herpes zoster reactivation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Lenalidomide:</strong> This drug is an immunomodulatory agent used in multiple myeloma and does not significantly increase the risk of herpes zoster reactivation compared to bortezomib. Its primary adverse effects include cytopenias and increased thromboembolic risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Daratumumab:</strong> Daratumumab is an anti-CD38 monoclonal antibody used in the treatment of multiple myeloma, especially in high-risk patients. While it can increase the risk of infections, it is not specifically associated with a high risk of herpes zoster reactivation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Melphalan:</strong> Melphalan is an alkylating agent used in multiple myeloma, primarily in patients undergoing autologous stem cell transplantation or in refractory cases. It is not particularly linked with herpes zoster reactivation, although it carries other significant toxicities.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bortezomib is associated with an increased risk of herpes zoster reactivation in patients with multiple myeloma, necessitating prophylactic antiviral treatment such as acyclovir to prevent this complication.</span></p>",
      "correct_choice_id": 233761,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58606/Neet_Pg_Aug_2024_Medicine_Q_33.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58606/Neet_Pg_Aug_2024_Medicine_Q_33.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58608,
      "choices": [
        {
          "id": 233769,
          "text": "<p><span style=\"font-size:12.0pt;\">IV Thiamine followed by IV dextrose</span></p>"
        },
        {
          "id": 233770,
          "text": "<p><span style=\"font-size:12.0pt;\">IV 5% Dextrose</span></p>"
        },
        {
          "id": 233771,
          "text": "<p><span style=\"font-size:12.0pt;\">IV Normal saline</span></p>"
        },
        {
          "id": 233772,
          "text": "<p><span style=\"font-size:12.0pt;\">IV Lorazepam</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old alcoholic patient was brought to the emergency in an unconscious state. His blood glucose was 49 mg/dL. What is the management? (NEET PG 2024)</span></p>",
      "unique_key": "Q3533274",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731603,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) IV Thiamine followed by IV dextrose</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with a history of chronic alcoholism presenting with altered mental status or unconsciousness, the possibility of Wernicke’s encephalopathy must always be considered. Wernicke’s encephalopathy is caused by thiamine deficiency, which is common in chronic alcoholics due to poor nutritional intake.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When a patient presents with hypoglycemia, as indicated by the blood glucose level of 49 mg/dL, immediate management usually involves the administration of dextrose. However, in an alcoholic patient, administering dextrose without first giving thiamine can worsen Wernicke’s encephalopathy. This is because glucose metabolism consumes thiamine, and giving dextrose first can deplete the already low thiamine stores, exacerbating neurological damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, it is crucial to administer IV thiamine before giving IV dextrose to prevent this worsening of symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. IV 5% Dextrose:</strong> Administering dextrose alone without prior thiamine administration can precipitate or worsen Wernicke’s encephalopathy in alcoholic patients due to increased thiamine demand during glucose metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. IV Normal saline:</strong> This option would not address the hypoglycemia or the underlying thiamine deficiency and is not an appropriate initial management step in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. IV Lorazepam:</strong> This is not indicated for the immediate management of hypoglycemia or Wernicke’s encephalopathy and could potentially worsen the patient’s altered mental status.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In alcoholic patients with altered mental status and hypoglycemia, always administer IV thiamine before IV dextrose to prevent the worsening of Wernicke’s encephalopathy.</span></p>",
      "correct_choice_id": 233769,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58608/Neet_Pg_Aug_2024_Medicine_Q_34.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58608/Neet_Pg_Aug_2024_Medicine_Q_34.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58610,
      "choices": [
        {
          "id": 233777,
          "text": "<p><span style=\"font-size:12.0pt;\">She has sensitivity only to aspirin.</span></p>"
        },
        {
          "id": 233778,
          "text": "<p><span style=\"font-size:12.0pt;\">She could have got this reaction with any other COX-1 inhibitors too.</span></p>"
        },
        {
          "id": 233779,
          "text": "<p><span style=\"font-size:12.0pt;\">Can be treated by Montelukast.</span></p>"
        },
        {
          "id": 233780,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin desensitization therapy can be helpful.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 54-year-old lady with multiple nasal polyps, rhinosinusitis, and asthma came to the dentist for a procedure. She recently developed an allergic reaction to aspirin that was prescribed after undergoing a dermatologic procedure. Which of the following statements is incorrect regarding her condition? (NEET PG 2024)</span></p>",
      "unique_key": "Q9311385",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731604,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>A) She has sensitivity only to aspirin.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient is exhibiting features of <strong>Aspirin-Exacerbated Respiratory Disease (AERD)</strong>, also known as Samter's triad. This condition includes a combination of asthma, nasal polyposis, and hypersensitivity to aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs). The pathophysiology of AERD involves dysregulation of the arachidonic acid pathway, where inhibition of the COX pathway by aspirin or NSAIDs shifts the metabolism towards the LOX pathway, resulting in excessive leukotriene production, which contributes to symptoms.</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Sensitivity to Multiple NSAIDs</strong>: AERD patients do not react exclusively to aspirin; they can react to other COX-1 inhibitors (other NSAIDs), which makes Option A incorrect.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment with Leukotriene Receptor Antagonists</strong>: Medications like Montelukast, a leukotriene receptor antagonist, help manage symptoms by blocking the effects of leukotrienes, which play a significant role in the condition.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Aspirin Desensitization Therapy</strong>: This can be beneficial in AERD, allowing patients to tolerate aspirin and potentially improving respiratory symptoms over time.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. She could have got this reaction with any other COX-1 inhibitors too</strong>: This statement is correct as any NSAID that inhibits COX-1 can trigger similar reactions in patients with AERD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Can be treated by Montelukast</strong>: This is correct because Montelukast helps manage the overproduction of leukotrienes, reducing symptoms associated with AERD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Aspirin desensitization therapy can be helpful</strong>: This statement is true. Desensitization can reduce reactivity to aspirin and improve clinical outcomes in AERD patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">AERD (Aspirin-Exacerbated Respiratory Disease) involves sensitivity to aspirin and other COX-1 inhibitors, leading to increased leukotriene production and symptoms that can be managed with leukotriene receptor antagonists and desensitization therapy.</span></p>",
      "correct_choice_id": 233777,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58610/Neet_Pg_Aug_2024_Medicine_Q_35.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58610/Neet_Pg_Aug_2024_Medicine_Q_35.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54259,
      "choices": [
        {
          "id": 216505,
          "text": "<p><span style=\"font-size:12.0pt;\">Chest compressions at 100-120/min</span></p>"
        },
        {
          "id": 216506,
          "text": "<p><span style=\"font-size:12.0pt;\">Allow adequate chest recoil</span></p>"
        },
        {
          "id": 216507,
          "text": "<p><span style=\"font-size:12.0pt;\">Chest compression to Rescue breath ratio is 30:2</span></p>"
        },
        {
          "id": 216508,
          "text": "<p><span style=\"font-size:12.0pt;\">Depth of compression must be 3-4cm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">&nbsp;Which of the following is incorrect regarding High-Quality CPR?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q8354104",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731605,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Depth of compression must be 3-4cm</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The statement \"Depth of compression must be 3-4cm\" is incorrect for high-quality CPR. The correct depth of chest compression for adults is approximately <strong>5 centimeters (or 2 inches). </strong>This depth ensures adequate blood flow during cardiopulmonary resuscitation. The 3-4cm depth mentioned in the option is insufficient for effective CPR in adults.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Chest compressions at 100-120/min:</strong> This is correct. The recommended rate for chest compressions during CPR is 100-120 compressions per minute. This rate optimizes blood flow during resuscitation efforts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Allow adequate chest recoil:</strong> This statement is correct. Allowing full chest recoil between compressions is crucial for effective CPR. It enables proper diastolic filling of the heart, improving overall circulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Chest compression to Rescue breath ratio is 30:2:</strong> This is also correct. For adult CPR without an advanced airway, the standard ratio is 30 chest compressions followed by 2 rescue breaths.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In high-quality CPR for adults, the correct depth of chest compressions is approximately 5 centimeters (2 inches), not 3-4cm as stated in the incorrect option.</span></p>",
      "correct_choice_id": 216508,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54259/INI-CET_May_2024Medicine_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54259/INI-CET_May_2024Medicine_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58612,
      "choices": [
        {
          "id": 233785,
          "text": "<p><span style=\"font-size:12.0pt;\">Add Fluticasone MDI two times a day</span></p>"
        },
        {
          "id": 233786,
          "text": "<p><span style=\"font-size:12.0pt;\">Shift to MDI Salmeterol two times a day</span></p>"
        },
        {
          "id": 233787,
          "text": "<p><span style=\"font-size:12.0pt;\">Add Prednisolone 10mg</span></p>"
        },
        {
          "id": 233788,
          "text": "<p><span style=\"font-size:12.0pt;\">Continue the current management</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 24-year-old male who is a known case of bronchial asthma presented for a routine follow-up. PFT was done earlier—his FEV1 was 70%, which improved to 83% after bronchodilator nebulization. He was already on MDI Albuterol daily. On questioning, it seems like he is being symptomatic for at least 2 times per week and is waking up in the nights due to symptoms at least once per week. On examination, there are scattered rhonchi. What should be done? (NEET PG 2024)</span></p>",
      "unique_key": "Q8444780",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731606,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>A) Add Fluticasone MDI two times a day</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient’s symptoms indicate that his asthma is not well-controlled with short-acting beta-agonist (Albuterol) alone. Inhaled corticosteroids (ICS), such as Fluticasone, are essential in asthma management because they address airway inflammation, which is a key component of asthma pathophysiology. Adding an ICS will help reduce symptoms, improve lung function, and prevent exacerbations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Shift to MDI Salmeterol two times a day:</strong> Salmeterol is a long-acting beta-agonist (LABA) that can help control symptoms but does not address the underlying inflammation. LABA should not be used as monotherapy in asthma without an accompanying ICS due to the risk of worsening asthma control.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Add Prednisolone 10mg:</strong> Prednisolone is a systemic corticosteroid, which is generally reserved for severe asthma exacerbations or patients who do not respond to standard therapy (steps 5 and 6 of the asthma management algorithm). Long-term use is associated with significant side effects, making it inappropriate for this patient’s current condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Continue the current management:</strong> Continuing the current management is not appropriate as the patient is symptomatic, indicating inadequate asthma control. Adjusting the treatment plan is necessary to improve his symptoms and prevent nighttime awakenings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Inhaled corticosteroids are the cornerstone of asthma management as they effectively reduce airway inflammation, improve symptoms, and prevent exacerbations. They should be added when asthma symptoms are not controlled by a short-acting beta-agonist alone.</span></p>",
      "correct_choice_id": 233785,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58612/Neet_Pg_Aug_2024_Medicine_Q_36.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58612/Neet_Pg_Aug_2024_Medicine_Q_36.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11253,
      "choices": [
        {
          "id": 44978,
          "text": "<p><span style=\"font-size:12.0pt;\">Normal ECG</span></p>"
        },
        {
          "id": 44979,
          "text": "<p><span style=\"font-size:12.0pt;\">Ventricular fibrillation</span></p>"
        },
        {
          "id": 44980,
          "text": "<p><span style=\"font-size:12.0pt;\">Ventricular tachycardia</span></p>"
        },
        {
          "id": 44981,
          "text": "<p><span style=\"font-size:12.0pt;\">Misplaced leads</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the diagnosis of this patient from the ECG shown below? (NEET PG 2019)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/23/screenshot-2024-07-23-130813.jpg\" alt=\"\" width=\"500\" height=\"285\"></p>",
      "unique_key": "Q1041955",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731607,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Ventricular tachycardia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The ECG displays a rhythm with broad QRS complexes at a high rate, consistent with ventricular tachycardia (VT). VT is characterized by three or more consecutive ventricular beats at a rate of more than 100 beats per minute. The presence of such a pattern, particularly with a stable, repetitive form as seen in the ECG, strongly points to VT rather than other types of arrhythmias.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Normal ECG:&nbsp;</strong>This option is incorrect as the ECG clearly shows an abnormal rhythm with broad QRS complexes, indicative of an arrhythmia originating below the AV node.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ventricular fibrillation:&nbsp;</strong>Ventricular fibrillation is characterized by irregular, chaotic electrical activity without identifiable QRS complexes, P waves, or T waves. The rhythm shown here is too organized and regular to be VF.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Misplaced leads:</strong></span><span style=\"font-size:14.6667px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12pt;\">Misplaced leads causes <strong>positive p in aVR</strong> <strong>with normal intervals</strong> - R wave progression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ventricular tachycardia is identified by regular, broad QRS complexes at a rapid rate, distinct from the irregular pattern of ventricular fibrillation and the organized, narrower complexes typically seen with supraventricular rhythms and correct lead placement. Identifying VT on an ECG is critical due to its potential severity and the need for prompt treatment.</span></p>",
      "correct_choice_id": 44980,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58613,
      "choices": [
        {
          "id": 233789,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypophosphatemic rickets</span></p>"
        },
        {
          "id": 233790,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin D dependent rickets 1</span></p>"
        },
        {
          "id": 233791,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin D dependent rickets 2</span></p>"
        },
        {
          "id": 233792,
          "text": "<p><span style=\"font-size:12.0pt;\">Nutritional Rickets</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presented with the following deformity. Labs show the following: Serum calcium - Normal, PTH - Normal, Phosphate - Low, ALP - Raised. What is the probable defect? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/25/screenshot-2024-09-25-125527.jpg\" alt=\"\" width=\"300\" height=\"361\"></span></p>",
      "unique_key": "Q7420355",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731608,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Hypophosphatemic rickets</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hypophosphatemic rickets is characterized by low serum phosphate levels, normal calcium, normal PTH, and elevated alkaline phosphatase (ALP). This type of rickets is not due to vitamin D deficiency but rather a phosphate metabolism disorder, often related to renal phosphate wasting. In hypophosphatemic rickets, PTH and calcium levels are typically normal, which helps differentiate it from other forms of rickets.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The normal calcium and PTH levels are the main clues in this case, as they help distinguish hypophosphatemic rickets from other conditions such as vitamin D dependent rickets types 1 and 2, where calcium would be low, and PTH would typically be elevated.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Vitamin D dependent rickets 1:</strong> This condition is due to a deficiency in 1-alpha hydroxylase, which impairs the activation of vitamin D. Patients typically present with low calcium and elevated PTH, which does not match the lab results shown here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vitamin D dependent rickets 2:</strong> This condition involves resistance to vitamin D due to a defect in the vitamin D receptor. Similar to type 1, calcium levels would be low, and PTH would be elevated, not matching this patient’s profile.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Nutritional Rickets:</strong> This condition is primarily due to vitamin D deficiency and would usually present with low calcium and elevated PTH, making it unlikely in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hypophosphatemic rickets presents with normal calcium, normal PTH, low phosphate, and elevated ALP, distinguishing it from other rickets types where calcium and PTH abnormalities are typically present.</span></p>",
      "correct_choice_id": 233789,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58613/Neet_Pg_Aug_2024_Medicine_Q_37.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58613/Neet_Pg_Aug_2024_Medicine_Q_37.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 58614,
      "choices": [
        {
          "id": 233793,
          "text": "<p><span style=\"font-size:12.0pt;\">NK1 agonist</span></p>"
        },
        {
          "id": 233794,
          "text": "<p><span style=\"font-size:12.0pt;\">NK3 agonist</span></p>"
        },
        {
          "id": 233795,
          "text": "<p><span style=\"font-size:12.0pt;\">NK1 antagonist</span></p>"
        },
        {
          "id": 233796,
          "text": "<p><span style=\"font-size:12.0pt;\">NK3 antagonist</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the mechanism of action of aprepitant? (NEET PG 2024)</span></p>",
      "unique_key": "Q2102105",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731609,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>C) NK1 antagonist</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Aprepitant is a Neurokinin 1 (NK1) receptor antagonist that works by blocking the action of substance P, a neuropeptide associated with the emesis reflex. It is primarily used to prevent chemotherapy-induced nausea and vomiting (CINV), especially in patients receiving highly emetogenic chemotherapy agents like cisplatin. By inhibiting NK1 receptors in the brain, aprepitant effectively reduces the incidence of nausea and vomiting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Aprepitant is an NK1 receptor antagonist used in preventing chemotherapy-induced nausea and vomiting by blocking the action of substance P.</span></p>",
      "correct_choice_id": 233795,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58614/Neet_Pg_Aug_2024_Medicine_Q_39.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/58614/Neet_Pg_Aug_2024_Medicine_Q_39.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73081,
      "choices": [
        {
          "id": 291289,
          "text": "<p><span style=\"font-size:16px;\">Hyperthyroidism relapse</span></p>"
        },
        {
          "id": 291290,
          "text": "<p><span style=\"font-size:16px;\">Thyroid storm</span></p>"
        },
        {
          "id": 291291,
          "text": "<p><span style=\"font-size:16px;\">Hypothyroidism</span></p>"
        },
        {
          "id": 291292,
          "text": "<p><span style=\"font-size:16px;\">Radiation-induced thyroiditis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old woman presents with weight loss, heat intolerance, and palpitations over the past two months. Laboratory tests reveal decreased TSH and elevated T3 and T4 levels. She is started on iodine-131 therapy. What is the most common long-term side effect of this treatment? (FMGE JAN 2025)</span></p>",
      "unique_key": "Q3708853",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731610,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Hypothyroidism</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>I-131 (radioactive iodine) therapy</strong> is commonly used for <strong>hyperthyroidism (Graves' disease)</strong>. The most <strong>common long-term side effect is hypothyroidism</strong>, due to:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Destruction of thyroid tissue</strong></span></li><li><span style=\"font-size:16px;\"><strong>Permanent reduction in thyroid hormone production</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Hyperthyroidism relapse:</strong> Rare, as <strong>radioactive iodine typically leads to permanent thyroid destruction</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Thyroid storm:</strong> Acute complication, <strong>not a long-term effect</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Radiation-induced thyroiditis:&nbsp;</strong>Can occur but is <strong>a transient complication</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Hypothyroidism is the most common long-term side effect of radioactive iodine (I-131) therapy, requiring lifelong thyroid hormone replacement.</span></p>",
      "correct_choice_id": 291291,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73081/FMGE_Jan_2025_Medicine_Q_-_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73081/FMGE_Jan_2025_Medicine_Q_-_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73082,
      "choices": [
        {
          "id": 291293,
          "text": "<p><span style=\"font-size:16px;\">Horner syndrome</span></p>"
        },
        {
          "id": 291294,
          "text": "<p><span style=\"font-size:16px;\">Brachial plexopathy</span></p>"
        },
        {
          "id": 291295,
          "text": "<p><span style=\"font-size:16px;\">Superior vena cava syndrome</span></p>"
        },
        {
          "id": 291296,
          "text": "<p><span style=\"font-size:16px;\">Exophthalmos</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A patient with a history of smoking presents with a cough and hemoptysis. A chest X-ray is done and it is shown below. Which of the following findings is least likely to be associated with this condition? (FMGE JAN 2025)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_3P9dJkp.png\" width=\"434\" height=\"369\"></span></p>",
      "unique_key": "Q7654990",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731611,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D)</strong> <strong>Exophthalmos</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The X-ray findings suggest a <strong>Pancoast tumor (superior sulcus tumor)</strong>, which can invade adjacent structures, causing:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Brachial plexopathy</strong> (compression of lower brachial plexus)</span></li><li><span style=\"font-size:16px;\"><strong>Horner’s syndrome</strong> (ptosis, miosis, anhidrosis) due to <strong>sympathetic chain involvement</strong></span></li><li><span style=\"font-size:16px;\"><strong>Superior vena cava syndrome</strong> due to <strong>compression of the superior vena cava</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Exophthalmos is more commonly associated with Graves’ disease</strong> and is <strong>not a feature of Pancoast tumors</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Horner syndrome:</strong> Incorrect because this is a common finding in Pancoast tumor due to involvement of the sympathetic chain</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Brachial plexopathy:</strong> Incorrect because this is commonly seen due to compression of the lower part of the brachial plexus by the tumor</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Superior vena cava syndrome:</strong> Incorrect because SVC syndrome can occur in Pancoast tumors due to compression or invasion of the superior vena cava</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Pancoast tumors present with Horner’s syndrome, brachial plexopathy, and superior vena cava syndrome, but exophthalmos is not part of the presentation.</span></p>",
      "correct_choice_id": 291296,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73082/FMGE_Jan_2025_Medicine_Q_-_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73082/FMGE_Jan_2025_Medicine_Q_-_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73083,
      "choices": [
        {
          "id": 291297,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-HBc</span></p>"
        },
        {
          "id": 291298,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-HBs</span></p>"
        },
        {
          "id": 291299,
          "text": "<p><span style=\"font-size:12.0pt;\">HBeAg</span></p>"
        },
        {
          "id": 291300,
          "text": "<p><span style=\"font-size:12.0pt;\">HBsAg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old patient diagnosed with chronic hepatitis B infection is being evaluated for infectivity status. Which of the following markers indicates high infectivity? (FMGE JAN 2025)</span></p>",
      "unique_key": "Q6934409",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731612,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) HBeAg</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>HBeAg (Hepatitis B e antigen)</strong> is a marker of <strong>viral replication and infectivity</strong> in chronic hepatitis B infection. Its presence indicates:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>High levels of viral replication</strong></span></li><li><span style=\"font-size:16px;\"><strong>Higher risk of transmission</strong></span></li><li><span style=\"font-size:16px;\"><strong>Greater infectivity</strong></span></li><li><span style=\"font-size:16px;\"><strong>Usually associated with higher HBV DNA levels</strong></span></li><li><span style=\"font-size:16px;\"><strong>Important prognostic marker for complications like cirrhosis and hepatocellular carcinoma</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option&nbsp;A. Anti-HBc:</strong> Indicates <strong>current or past HBV infection</strong>, but <strong>not infectivity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option&nbsp;B. Anti-HBs:</strong> Indicates <strong>immunity</strong> (through vaccination or recovery), <strong>not infectivity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option&nbsp;D. HBsAg:</strong> Indicates <strong>infection</strong>, but <strong>does not differentiate between high and low infectivity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">HBeAg is a key marker of high viral replication and infectivity in chronic hepatitis B infection.</span></p>",
      "correct_choice_id": 291299,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73083/FMGE_Jan_2025_Medicine_Q_-_21.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "Factual",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73083/FMGE_Jan_2025_Medicine_Q_-_21.mp4",
      "question_images": [],
      "explanation_images": []
    }
  ]
}